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GW researchers lead a five‑year, 
multimillion‑dollar grant to 
explore immunotherapy as a 
means to end HIV.
A NOTE FROM ROSS HALL
BELIEVE is the acronym for the title of the landmark $28 
million, five-year National Institutes of Health grant awarded 
to GW School of Medicine and Health Sciences (SMHS) 
faculty members to work toward a cure for HIV/AIDS. Of 
course, it also reflects the confidence that this remarkable 
team of researchers and clinicians has to advance our 
knowledge of the immune system and our ability to clear HIV 
from the body.
Believe is also the theme of this edition of Medicine + 
Health. What links these articles is our collective belief in the 
SMHS mission and in our outstanding students, residents, 
fellows, faculty, alumni, and staff. These stories reflect the 
amazing work that takes place at SMHS every day.  
Whether you gain inspiration from our diverse student 
body and residents in pursuit of their calling to be leaders 
in medicine and health care; are excited by the advances in 
the basic sciences, translational or clinical research; or are 
moved by the impact that our faculty and alumni have on the 
communities in which we serve, I hope that you find reasons to 
believe in SMHS and make gift to support these efforts.
Philanthropy is an important way for you to express your 
belief in SMHS. An unrestricted gift or a gift made to the 
dean’s discretionary fund will be used for student scholarships 
— my number one priority. However, our terrific faculty also 
require support for their efforts to create innovative teaching 
models, to perform groundbreaking research, and to provide 
cutting-edge clinical care. Giving opportunities are unlimited. 
If something in this edition does not match your interests, I 
encourage you to pull up the school’s website (smhs.gwu.edu) 
and see what else is taking place at SMHS.
Warmest regards,
JEFFREY S. AKMAN, M.D. ’81, RESD ’85
VICE PRESIDENT FOR HEALTH AFFAIRS 
WALTER A. BLOEDORN PROFESSOR OF ADMINISTRATIVE MEDICINE 
DEAN, SCHOOL OF MEDICINE AND HEALTH SCIENCES
Dear members of the SMHS community,
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MAKING THE ROUNDS
It’s an oft‑used metaphor, but in the 
case of GW School of Medicine and 
Health Sciences students, it’s apt: 
Graduation is the end of a chapter in a 
long story of health care. For medicine 
and health sciences students, it’s a 
narrative of intense study, little sleep, 
and immense personal growth. 
As the graduates of 2016 learned, 
the next act of their professional lives 
hinges on their ability to build on 
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Harris, M.B.A., PMP, as the senior 
associate dean for administration and 
operations, a new position within the 
Office of the Vice President for Health 
Affairs and Dean of SMHS. Harris 
comes from the U.S. Food and Drug 
Administration, where he served as 
the deputy commissioner for opera‑
tions and chief operating officer. At 
SMHS, he will spearhead business 
and management efforts designed 
to balance strategic and operational 
initiatives. He will also be responsible 
for SMHS operations and adminis‑
tration, including communications, 
strategic planning, financial planning 
and accounting, information tech‑
nology, human resources, facilities, and 
safety and security. 
Harris has won multiple awards 
and honors, including the Executive 
Leadership in Government Award from 
the Association for Federal Information 
Resource Management, the Top 
Blacks in Healthcare Award from 
BlackDoctors.org, and the Centers for 
Disease Control Directors Award. He 
also served as a sergeant in the United 
States Air Force and was selected as 
the Pentagon liaison to Secretary of 
Defense Caspar Weinberger. 
“Coming to the GW School of 
Medicine and Health Sciences is a 
wonderful next step in my career,” 
Harris said. “I am pleased to be joining 
a dynamic team.”  
compassion and collaboration, as they 
move to residencies, internships, and 
clinical care. 
“[Your story] is only partially 
written, but it’s off to a great start,” 
M.D. program graduation keynote 
speaker Jonathan B. Perlin, M.D., Ph.D., 
M.S.H.A., MACP, FACMI, president 
of clinical services and chief medical 
officer of the Hospital Corporation of 
America. “Bravo!”  
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The white coat: a piece of fabric whose 
meaning belies its simplicity. It repre‑
sents a responsibility to patients; a 
commitment to healing; and a passion 
for the craft of medicine. For new 
students, slipping into the white coat 
also signifies entry into the profession, 
a milestone treated with ceremony. 
Meron Rezene, a senior at E.L. Haynes Public Charter 
School in Washington, D.C., waits to deliver a baby in the 
Clinical Learning And Simulation Skills Center during the 
annual four-week DC Health and Academic Preparation 
Program (DC HAPP). The program, designed to immerse 
rising high school seniors in the field of medicine, 
includes lectures, poster presentations, and hands-on 
activities, such as lessons in suturing and CPR training. 
The DC HAPP cohort also receives white coats, a symbol 
of entry into health care, in a special ceremony.  
DONNING THE 
WHITE COAT 
First‑year M.D. program students 
formally donned their white coats in early 
August; physician assistants, as well as 
incoming residents, received their white 
coats in late June. Physical therapy (PT) 
students, with help from second‑ and 
third‑year PT students, put on theirs in 
the fall. 
“This has been the last eight years 
of my life, trying to get to this point, 
and it feels like a dream that I really 
don’t want to wake up from,” said first‑
year M.D. student Paola Mancera at her 
ceremony. “I’m on the verge of crying 
and trying not to cry this soon, but it is 
the most surreal experience.”  
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Students in the GW School of Medicine 
and Health Sciences (SMHS) M.D. 
program could easily be spotted 
among the deluge of people eager 
to attend the opening of the National 
Museum of African American History 
and Culture, but they weren’t there as 
spectators. Instead, the students and 
SMHS faculty were on hand to provide 
an important service during the 
historic event. 
The GW Medical Faculty 
Associates (GW MFA) Department of 
Emergency Medicine was called upon 
to provide medical support at the 
event, and at least a half dozen medical 
students volunteered their time and 
services throughout the weekend, said 
Yolanda Haywood, M.D., RESD ’87, 
B.A. ’81, associate dean for diversity, 
inclusion, and student affairs at SMHS. 
During the opening, students 
took blood pressure, attended to 
minor wounds, and assisted the 
medical team triaging the injured or 
ill attendees. The opportunity put 
students at the center of the action 
providing medical care at a large 
public event, Haywood said. 
Jené Carter, a second‑year 
medical student who volunteered at 
the event, said she participated in 
order to put into practice the skills she 
had learned in class while also being 
part of “a huge, historic moment.” 
Washington, D.C. is a vibrant city 
full of events and festivals, and for 
GW medical students, volunteering 
at activities that only this city holds “is 
really valuable,” Carter said. 
She added that she felt a bit 
nervous about having the right skills 
required for whatever might come 
up, but found comfort in the sense of 
teamwork among the students, nurses, 
and providers. “Everyone was really 
collaborative,” she said. 
Occasions such as the museum 
opening, Haywood added, show 
students how much organization and 
skill is required to provide medical 
care at a large event. And with one so 
momentous, “just to be part of that was 
a great opportunity, no matter what 
your role was,” she said. 
GW students and staff will also 
play a role at an event that’s completely 
unique to D.C.: the presidential 
inauguration. 
The GW MFA Medical Reserve 
Corps (MRC), a medical response 
and disaster team, is gearing up for 
Service Learning: As part of the annual SMHS 
Community Service Day, first‑ and second‑year M.D. 
program students, as well as doctor of physical therapy 
students, split into shifts to volunteer with a variety of 
organizations: Nourishment Now, Operation Smile, Best 
Buddies, the Children’s Inn at the National Institutes of 
Health, and the Audubon Naturalist Society. 
“I think [volunteering] is something not a lot of people 
take the time to step out of their comfort zone to do, so 
it was really nice to take that extra step and bring this to 
people’s doorstep so they can see the impact that they’re 
making in people’s lives,” said co‑chair Robyn Frankel, a 
second‑year medical student. “It’s pretty meaningful.”
the event, most recently holding an 
active shooter medical response drill 
in partnership with the U.S. Park Police, 
as well as D.C. police, fire, and EMS 
departments, among others, said Drew 
Maurano, PA‑C, director of event and 
operational medicine and GW MRC, 
and associate clinical professor of 
emergency medicine at SMHS. 
Faculty and staff took part in the 
drill, with about 15 medical and physi‑
cian assistant (PA) students acting 
as responders, and more than 100 
medical, nursing, and PA students 
playing the role of victims. Six SMHS 
faculty members were present to help 
lead the drill, Maurano said, praising 
the level of “involvement from the 
medical students and medical faculty.” 
Carter expressed interest in 
the drill, which she said is necessary 
because horrible things happen — and 
as an aspiring physician, it’s important 
to be prepared for anything. 
As for the part medical students 
and faculty will play at the inaugura‑
tion and events surrounding it, that 
will come down to the needs of the 
inauguration committee put in place 
by the presidential transition team, 
Maurano said.  
Practical Medicine in the Historical Setting
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Becoming “One GW” 
From undertaking innovative research 
and treatment to educating health 
care professionals, the GW School of 
Medicine and Health Sciences (SMHS), 
the GW Hospital, and the GW Medical 
Faculty Associates have established 
a foundation of collaboration and 
achievement. Now, however, the three 
— under the umbrella “One GW” — are 
strengthening their bond with a new 
alignment and structure. 
One GW has three goals: offering 
patients the most comprehensive and 
highest quality of care; training the 
next generation of medical profes‑
sionals with technically advanced 
clinical techniques and modalities; and 
advancing biomedical, translational, 
and health services delivery research 
to improve patient outcomes.
This new approach will allow each 
medical entity to better combine its 
efforts and resources on key service 
lines and research opportunities. 
Additionally, One GW will empower 
physicians to participate in a shared 
governance model, providing them 
with a more active role in decision‑
making and planning for success.
To celebrate the launch of One 
GW, the three entities welcomed 
nearly 4,000 employees, staff, resi‑
dents, and students for a catered 
meal, complete with ginger‑glazed 
pineapple and jerk pork, corn on the 
cob, and ice cream, held in the Eye 
Street Mall in mid‑September.  
Going Global on 
Regulatory Science
Industry experts, working profes‑
sionals, and students from both the 
Regulatory Affairs Program at the 
GW School of Medicine and Health 
Sciences (SMHS) and abroad gathered 
in Foggy Bottom for the first interna‑
tional annual summer institute, “Issues 
& Trends in Regulatory Science.” 
The event, organized through a 
collaboration between SMHS and the 
European Center of Pharmaceutical 
Medicine at the University of Basel, 
Switzerland, featured prominent 
industry leaders and discussions on 
topics like how health care products 
are cleared or approved for marketing; 
the future of drug and medical device 
innovations; how the reimbursement 
process works; pending legislation that 
might change the way health care is 
delivered; and the One Health Initiative 
that aims to improve health care for all.
“It was an invaluable experience,” 
said Emily Swanson‑Parker, a class of 
2017 student in the SMHS Regulatory 
Affairs program. “[This] wasn’t your 
run‑of‑the‑mill professional confer‑
ence, and I think that’s what made this 
conference stand out.”  
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Yarne Glascoe poses in the gym where 
she works out, strengthening her body 
after surgery. A few months before, 
Glascoe received a kidney donation 
at the GW Transplant Institute at GW 
Hospital. Glascoe was one of several 
patients who received a new kidney 
this year. As of December 2016, the 
Transplant Institute, with surgeons J. 
Keith Melancon, M.D., chief of the GW 
Transplant Institute and professor of 
surgery at the GW School of Medicine 
and Health Sciences (SMHS); Thomas 
Jarrett, M.D., chair and professor of 
urology at SMHS; and Muralidharan 
Jagadeesan, M.B.B.S., associate 
professor of medicine at SMHS, 
New Head for Health 
Sciences
Reamer L. Bushardt, Pharm.D., PA‑C, 
DFAAPA, tenured professor and chair of 
the Department of Physician Assistant 
(PA) Studies at Wake Forest Baptist 
Medical Center’s School of Medicine, 
was named senior associate dean for 
health sciences at the GW School of 
Medicine and Health Sciences (SMHS). 
Bushardt will lead all health sciences 
departments at SMHS, including the 
departments of PA studies, physical 
therapy and health care sciences, 
clinical research and leadership, and 
integrated health sciences. 
In addition to leading the 
Department of PA Studies at Wake 
Forest, Bushardt was a professor in 
the Department of Internal Medicine, 
professor and program leader in Wake 
Forest’s Clinical Translational Science 
Institute, and professor in the W.G. 
Hefner VA Medical Center. 
As an active researcher engaged 
in health workforce and educational 
research projects, Bushardt has 
published extensively on the education 
and training of health care professional 
students and leaders, interprofessional 
education, and collaborative practice 
models. He also serves as editor‑in‑
chief for the Journal of the American 
Academy of Physician Assistants. 
Bushardt will assume the role 
of senior associate dean for health 
sciences on Jan. 1, 2017. 
Stepping down from this position 
is Joseph Bocchino, Ed.D. ’03, M.B.A., 
who served as senior associate dean for 
health sciences for the last four years.  
has performed more than 80 
kidney transplants. 
Working in concert with the 
GW Transplant Institute is the GW 
Ron and Joy Paul Kidney Center, 
which recently kicked off a major 
kidney health education campaign. 
Bus, television, radio, and digital 
media advertisements encour‑
aging Washington, D.C. residents 
to check their kidney health will 
appear throughout the year. The 
campaign will also include informa‑
tion sessions and free screenings, 
particularly in Wards 7 and 8, where 
kidney disease is widespread. 
Passing with Flying Colors 
Graduates from the GW School of 
Medicine and Health Sciences (SMHS) 
Physical Therapy (PT) Program have, for 
the seventh consecutive year, achieved 
a 100 percent first‑time pass rate on the 
National Physical Therapy Examination 
(NPTE). The NPTE is a rigorous, compre‑
hensive exam that all PT graduates must 
pass in order to be eligible for licensure. 
“This level of success is exemplary 
and a testimony to our strong graduates, 
our excellent faculty, and a curriculum 
reflective of contemporary practice 
standards,” said Joyce Maring, Ed.D., 
DPT, program director for the Doctor of 
Physical Therapy program and chair of 
the Department of Physical Therapy and 
Health Care Sciences at SMHS.  Reamer L. Bushardt, Pharm.D., PA‑C, 
DFAAPA
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The George Washington University Institute for Spirituality and Health (GWish), established in 
2001 to promote whole-person care by 
integrating spirituality into health care 
and education, marked a milestone this 
year: its 15th anniversary. To commemo-
rate the occasion, GWish welcomed 
members of the community, including 
political and academic luminaries, to a 
special dinner. 
“I think 15 years is amazing,” 
said Kathryn M. Braeman, chair of 
the GWish Advisory Board, as she 
acknowledged the work of GWish 
founder and director Christina 
Puchalski, M.D. ’94, RESD ’97, FACP, 
FAAHPM. “[Dr. Puchalski] has been 
a pioneer in creating awareness of the 
importance of spirituality in health. She 
is a visionary on a national and global 
scale.” 
Thanks to Puchalski and GWish’s 
efforts, spirituality is now recognized 
as a vital contributor to health — a 
prominent theme throughout the 
evening. In addition to Braeman’s 
introduction, U.S. Representative 
Fred Upton from Michigan’s 6th 
District and keynote speaker Robert 
Boisture, president and CEO of the 
Fetzer Institute, acknowledged the 
organization’s work. 
“We’re here to celebrate a wonderful 
cause,” Boisture said. Those in 
attendance, he explained, though 
they may come from a variety of 
backgrounds, cultures, and religions, 
share a passion. “The common 
denominator, I think,” he said, “is 
compassion, is opening our hearts to 
the pain and suffering of the world 
with hope and a commitment to try 
to do something about it.” 
With that compassion in mind, 
GWish presented its inaugural 
Excellence in Interprofessional 
Spiritual Care Award to Betty Ferrell, 
Ph.D., M.A., FAAN, FPCN, CHPN, 
director and professor in the Division 
of Nursing Research and Education, 
Department of Population Sciences, at 
City of Hope Hospital. 
“I don’t at all take this lightly, this 
recognition, because I know I’m in a room 
of many kindred spirits and people who 
are dedicated to ideas about love and 
spirituality,” Ferrell said. “I think for many 
of us in the room, there is the work we are 
asked to do every day, but deep within us 
there’s the work that we were born to do.” 
That’s the work, she said, that GWish 
does: attending to people’s spiritual needs 
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imberly Russo, M.B.A., M.S., pauses in the descrip-
tion of her hometown, White Hall, Illinois, 
population 1,100, to mock-gasp. “Everyone was like, 
‘We have a stoplight!’” The flashing red light, which 
was installed when Russo was in high school, was “a very, very 
big deal,” she explains, laughing. But Russo wasn’t meant for 
life in a one-stoplight town, though rural health care has always 
remained near and dear to her heart. She did stay in her home 
state, at first, attending Illinois State University, then graduate 
school at Rush University and a fellowship in speech-language 
pathology at a Northwestern University affiliate, until oppor-
tunities steered her in another direction. Here, the new CEO 
and managing director of GW Hospital discusses the path that 
took her from clinical care to hospital management, what that 
means — or doesn’t mean — for women breaking through glass 
ceilings, and her vision for the hospital.
Q: Tell me about your transition from academia and clinical 
work to hospital administration. 
A: I did my fellowship at a Northwestern affiliate for 
speech-language pathology/audiology and then my husband 
and I moved to the D.C. area for his career; I ultimately 
landed here at GW Hospital as a clinician and a bedside 
speech-language pathologist. I proceeded through the 
management path at GW, and I was actually in my Ph.D. 
program at the University of Maryland when I got some 
opportunities within GW; I really needed to take a leave 
of absence from my Ph.D. studies in order to pursue them. 
I made a critical decision and took a risk, which I think is 
sometimes part of leadership — you have to take those risks. 
I absolutely loved [going down the management path] and 
felt that I was making a larger impact and a difference in a 
very meaningful way.
I proceeded to administration and earned my M.B.A. 
during my first administrator role, feeling that I needed to go 
back and really continue to educate myself on the business and 
leadership philosophies. [I was then] chief operating officer 
for seven years and ultimately became the CEO following that 
stint in administration. 
Q: What were you pursuing as your Ph.D.? 
A: It was in speech-language pathology and audiology with a 
focus on neuropsychology and aphasiology. So, very interesting 
[laughs]. It really was on working memory, post-stroke, those 
types of things. 
Q: What was it like switching from that to an M.B.A.? 
A: You know, it’s a different animal, but I promised my 
husband it would be my last degree. I am very much an 
academician at heart and would be in school all the time if I 
could. I love higher education and learning, so for me, it was 
something I felt I needed for my own career path and also to 
KIMBERLY 
RUSSO:  
On Learning, Goals, 
and Her New Role as 
CEO of GW Hospital
BY CAROLINE TRENT-GURBUZ
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develop my knowledge and my critical thinking skills to really 
be successful in the administrative role. 
Q: Do you miss clinical work with speech-language pathology? 
A: I miss that direct patient contact and the clinical aspect 
of it. However, in this role, I feel that I’m able to fulfill that 
void by being out and about and rounding with the staff. I feel 
that my clinical background helps me not to be hesitant or 
nervous; I’m able to use my speech degree and communication 
to connect with patients in a more meaningful manner than is 
typical for administrators. 
Q: Does your clinical background make you, as an administrator, 
feel better able to handle whatever situations come up? 
A: I think having the clinical background, coupled with the 
business education and the experience that I’ve been blessed to 
have throughout my career, has really shaped and prepared me 
for the role. I’m able to bring that clinical perspective and keep 
the patient in the forefront of all the decisions that we make. I 
pride myself on doing that. I do think it makes a little bit of a 
difference; I can understand some of the clinical “asks” as well 
as the business “asks” that come into this role, and it also helps 
me more easily navigate through the priorities. 
Q: In terms of the hospital itself, what goals do you have? 
A: GW Hospital wants to continue — and my vision is to 
continue — the real focus on our academic-quaternary-tertiary 
center and serving the community’s needs during critical 
medicine and complex care. Being a quaternary center means 
that we are able to offer the D.C. region a level of specialized 
care that is not widely available elsewhere, including advanced 
technology and procedures. 
As we continue to expand and increase our level of care, we 
remain committed to our alignment with the School of Medicine 
and Health Sciences as well as the GW Medical Faculty 
Associates. Together, we make up the GW clinical enterprise, 
and we are able to offer comprehensive, research-based care. 
One area that we will focus on together in the coming 
years is our cancer program, which is a strategic initiative and 
growth imperative for the clinical enterprise. In addition to 
that, in order to really fulfill that academic-quaternary-tertiary 
vision, we have to continue to offer complex medical care, which 
involves highly complex surgery, trauma, and transplants. That 
has to be [paired] with innovative research and bringing new 
technologies and new procedures to the region — that’s really 
where the clinical enterprise is aligned, in pushing that vision. 
Q: Why is the continued alignment with the GW School of 
Medicine and Health Sciences and the GW Medical Faculty 
Associates important to your vision? 
A: As an academic medical center, we are committed to training 
the next generation of health care providers. The School of 
Medicine and Health Sciences is part of the fabric of who we are 
as a hospital. That strategic vision of alignment — being able to 
expand our footprint as an enterprise and provide the highest-
quality service to meet the community’s needs by offering 
greater accessibility — is key for that clinical enterprise. 
Q: What valuable asset does GW Hospital bring to the table 
for that alignment? 
A: We talk about the vision of the hospital, and we always have 
our business imperatives at the forefront of our mind — but I’ve 
been very focused on staff as well. I am committed to making 
GW Hospital not only a provider of choice for patients but also 
an employer of choice. 
I think the staff are really the heart of this organization, 
and they are the reason we’ve been able to provide the care 
and the health care access to our patients. In an effort to 
engage staff, I’ve recently started an employee advisory 
council. They want to know that their voice is being heard, 
and it is my job as a leader to ensure that I am welcoming their 
ideas and addressing their concerns. The staff are, to me, our 
most valuable asset, and we want to continue to develop and 
recognize and engage them to help us provide better service to 
our community. 
Q: There aren’t too many female hospital CEOs. How do you 
feel about rising to this level? Do you feel like you’ve broken a 
glass ceiling? 
A: I think it’s important to constantly keep in the forefront of 
the mind that you’re hired for your knowledge and skills and 
leadership to fulfill an objective. I have a pretty big objective to 
fulfill here as CEO. I don’t think it’s really about being male or 
female; it’s about the skills that you bring to the table to fulfill 
those objectives at the time. It is absolutely a rare situation — 
between 1.6 and 2.6 percent of health care leaders are female 
CEOs, and there are about 5,700 hospitals in the nation — and 
I believe there are continued gender diversity issues within the 
health care industry. 
It is, absolutely, a humbling experience. I’m very honored 
to be the CEO of GW Hospital and to be part of the clinical 
enterprise that I think is very strong, given that the medical 
school is one of the oldest in the nation and we have the largest 
faculty plan in the region. That, to me, is very humbling.   
The staff are, to me, our most 
valuable asset, and we want to 
continue to develop and recognize 
and engage them to help us provide 







he patient was addicted to heroin, 
recalls Katharine Hindle, M.D., 
assistant professor of anesthesiology 
and critical care medicine at the 
GW School of Medicine and Health 
Sciences (SMHS). GW Hospital staff 
screen all incoming emergency room 
patients for opioid and drug use — it’s 
standard operating procedure — and Hindle, in talking with 
the patient, found that he was actively using the drug. Digging 
deeper, she learned that he was self-medicating for hip pain. 
“He was at the point where he was very candid about the 
fact that he didn’t want to continue,” she says. “His goal was to 
go home on no additional opioids.” 
Managing his pain as part of that goal is precisely what 
Hindle and the Acute Pain Management Service, led by Paul 
Dangerfield, M.D. ’95, RESD ’02, B.S. ’89, assistant professor of 
anesthesiology and critical care medicine at SMHS, can offer. It 
is, Dangerfield says, the team’s small way of taking a bite out of 
opioid addiction. 
Statistically speaking, opioid addiction has cracked the 
level of epidemic. Since 1999, sales of prescription painkillers — 
oxycodone, hydrocodone, morphine, fentanyl, codeine — have 
quadrupled, according to the Centers for Disease Control and 
Prevention. Four in five heroin users first become addicted 
by misusing painkillers, the American Society of Addiction 
Medicine reports, and drug overdose is the leading cause of 
accidental death in the country. 
Using opioids, Dangerfield explains, is like treating pain 
with a hammer, rather than a needle: Opioids target pain “in 
a blunt way, in that they not only target the pain, but they 
target everything else,” he says, which can lead to undesirable 
side effects. Dangerfield also warns that bluntly targeting the 
pain doesn’t completely eliminate it, leading to an escalation 
in dosage, which puts the patient at higher risk for addiction 
and other negative side effects (nausea, vomiting, constipation, 
dysphoria). At GW Hospital, however, the Acute Pain 
Management Service is combining medications and techniques 
to more precisely target pain and reduce the need for opioids 
almost completely. 
“We use a number of different medications that work in 
different ways on the pain, what we call regional anesthesia,” 
Dangerfield explains. “If people need it, they get opioids — but 
instead of that being the foundation of what we’re doing, our 
goal is, through this multimodal pain regime, [to give them 
fewer] opioids. If people aren’t exposed to them in the first 
place, they’re less likely to become addicted to them, and their 
pain is treated effectively.” 
BY CAROLINE TRENT-GURBUZ
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After being diagnosed with breast cancer, Robyne Doyle 
opted for the multimodal approach for her double mastectomy 
and breast reconstruction because, she says, “I know pain.” 
Doyle was a nurse in the GW Hospital ICU for almost 30 
years. “I think some people who are not in the medical field 
don’t have a grasp of how painful that surgery is,” she says. “I 
was fully aware. It’s not a walk in the park.” 
Dangerfield treated Doyle with the paravertebral nerve 
block, a kind of regional anesthetic. Doyle had two small, 
flexible catheters inserted in her back, one on each side, that 
continually released medication over the course of a few days, 
a time period determined by the team. The catheters were 
connected to a softball-sized, portable bag of medication kept 
in pouches, which Doyle strapped around her waist. 
Despite having opioids or painkillers on hand in case her 
postoperative pain became overwhelming, Doyle found that 
it was nearly nonexistent. “When I got home, I still wasn’t in 
pain. I mean, I’m toddling around — most people are down for 
the count for five to seven days, writhing in pain, can’t get out of 
bed, can’t move around; that’s just the nature of the mastectomy. 
Here, I’m hanging out with my kids, walking my kids to the bus 
stop, doing dishes the minute I get home.” 
As Dangerfield explains, Doyle’s experience isn’t unusual: 
“Here’s someone who goes under, on a lot of different levels, 
a very significant surgery. She feels well enough to do [daily 
activities], as opposed to the patients who don’t get this 
[treatment] who are really laid up for a while and are not only 
miserable from the pain, but miserable from the side effects of 
the medication.” 
Looking back, Doyle believes the multimodal approach 
was a kind of gift, a blessing even, that she learned was 




• IV therapy (morphine) 
• Anti-inflammatory 
• Bupivacaine (epidural) 
• Muscle relaxant 
• Pills (opioids) 
someone’s sister-in-law — would get diagnosed, and I would 
tell them all about this procedure,” Doyle recalls. “Of course, 
they had never heard of it, and I almost felt bad talking about it 
because I felt like it was a special gift I had been given. I guess 
[although] GW does them, not every hospital does.” 
GW Hospital, the Acute Pain team explains, is one of 
the few institutions using this multimodal approach — but 
not because it’s so “super-secret and super-special that we’re 
the only ones who can figure it out,” Dangerfield says. The 
issue, he says, is a lack of education on pain treatment options: 
combinations of the regional anesthetics, ketamine infusions, 
IV therapy, anti-inflammatories, and muscle relaxants. 
To combat that lack of knowledge, SMHS has made pain 
management a component of the medical curriculum. Students 
rotate with the team for two to four weeks, and Marian 
Sherman, M.D. ’99, assistant professor of anesthesiology 
and critical care medicine at SMHS, lectures on the topic. 
Likewise, the team, says member Jessica Mersinger, an R.N. at 
GW Hospital, is “approachable and willing to educate, so we 
have residents who rotate through the service, who work with 
us managing the medications, and they take that back to their 
colleagues, [such as] the orthopedic team.” 
“The Pain Cave,” as the Acute Pain team office is known, 
also has a reputation for luring in GW Hospital health care 
staff through treats — especially Oreos — in order to discuss 
pain management options. “Even if it’s not an official consult, 
people will know who we are and stop us and say, ‘What do 
you think about this? Could I try this, could I try that?’” 
Dangerfield says. “It’s being that Pied Piper to get as many 
people as possible to do what we do.” 
The benefits of the Acute Pain Management Service 
extend far beyond just mitigating suffering for those undergoing 
surgery; surgeons who use the Acute Pain team find that their 
patients’ satisfaction increases, as does their practice, and 
patients feel cared for, thanks to the service’s 24/7 availability 
by phone and counseling options. It’s what makes the program 
special, Dangerfield adds: GW Hospital not only provides for 
the service, but also provides for support staff — four nurses 
and two nurse practitioners — to make sure patients receive 
comprehensive care at all times. “It’s truly what sets us apart,” he 
says. The team plans to add telemedicine soon, as well. 
“If all hospitals had an acute pain service that treated 
those patients [addicted to opioids] effectively, there would be a 
lot fewer patients going out on the street with Price Club-sized 
containers of opioids or going out and getting street drugs to 
treat their pain because the doctors didn’t treat it correctly,” 
Dangerfield says. “One mistake did not get us here, and one 
correction is not going to get us out. But if every hospital 
adopted what we did, it would be a big step in getting ahead of 
the initial problem.”   
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T
he GW School of Medicine and Health Sciences 
(SMHS) received full accreditation for an eight-
year term from the Liaison Committee on Medical 
Education (LCME), June 22. The accreditation 
process, which determines whether an M.D. program meets 
established LCME standards, involves an intensive three-day 
site visit. Programs must demonstrate that graduates exhibit 
professional competencies appropriate for the next stage of 
training, and those competencies need to serve as a founda-
tion for lifelong learning and proficient medical care. 
“This is an outstanding outcome — and I am grateful to 
the incredible team of students, faculty, staff, and deans who 
worked extremely hard to achieve this result,” says Jeffrey S. 
SMHS Receives Full,  
Eight-Year Accreditation
Akman, M.D. ’81, RESD ’85, vice president for health affairs, 
Walter A. Bloedorn Professor of Administrative Medicine, and 
dean of SMHS. 
The formal LCME report indicated that the SMHS M.D. 
program was in compliance with all accreditation standards, 
with two classified as “compliance in need of monitoring.” 
“This was a remarkable accreditation survey that gives 
us much to be proud of,” says Richard J. Simons, M.D., 
senior associate dean for M.D. programs, who led the 
LCME accreditation effort for SMHS. “As we move forward, 
we will continue to strive for excellence on all levels of 
medical education.”   
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W hat we learn about childhood diseases today can potentially affect present efforts in fighting ailments plaguing adults — and the partnership between the George Washington University 
(GW) School of Medicine and Health Sciences (SMHS), 
the Milken Institute School of Public Health at GW, and 
Children’s National Health System (Children’s National) is 
allowing for significant strides, thanks to the Clinical and 
Translational Science Award (CTSA).
The $23 million grant represents not just a five-
year extension to the original award the partnering 
institutions received in 2010, but it also is an expansion of 
the organizations’ original goals: enhancing clinical and 
translational research; overcoming research barriers and 
promoting collaborative research; providing research training; 
and focusing on health disparities and childhood forerunners 
to adult diseases. 
The partnership, known as the Clinical and Translational 
Science Institute at Children’s National (CTSI-CN), continues 
Translating 
OPPORTUNITY
GW’s School of Medicine and Health Sciences, the 
Milken Institute School of Public Health at GW, and 
Children’s National Health System Earn Renewal 
of their Five-Year Clinical and Translational 
Science Award
to be the only CTSA program out of the 64 in the nation with 
an emphasis on children, according to Robert Miller, Ph.D., 
senior associate dean for research, Vivian Gill Distinguished 
Research Professor, and professor of anatomy and regenerative 
biology at SMHS.
Lisa Guay-Woodford, M.D., director of the CTSI-CN, 
Richard L. Hudson Professor of Pediatrics at Children’s 
National, and associate vice president for clinical and 
translational research at GW, says the second version of the 
CTSA will answer a few central questions: What are the 
challenges for child health in translational science? How can 
we help investigators who want to take them on?  How can we 
help these investigators in developing studies that can be done 
across the consortia? And, from an extended perspective, how 
can we interact with other CTSA programs to develop best 
practices from which all can benefit?  
“I think the CTSA program nationally is all about being 
sure that people are really prepared to do effective clinical and 
translational research, to do it an efficient way where we don’t 
BY ERIC BUTTERMAN
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waste people’s time or resources, and 
where we really kind of get to the nut of 
the issue as quickly as possible,” Guay-
Woodford says. 
To maximize that efficiency, 
CTSI-CN will use the renewal grant 
to focus on informatics, workforce 
development, collaboration, and 
community engagement.
BY THE NUMBERS
Informatics, or the science of 
information, is right out in front in 
terms of the CTSA program’s focus. 
Informatics holds the power to advance 
care, but challenges remain in the 
collection and sharing of patient data, 
says Lawrence Deyton, M.D. ’85, 
M.S.P.H., senior associate dean for 
clinical public health and professor of 
medicine at SMHS, and co-director of 
the regulatory knowledge and science 
core for CTSI-CN. 
“There are many disciplines 
crossing and in different kinds of 
research,” Deyton says. “It goes from 
basic lab research to genetics research 
to even public health research. But for 
all aspects, there are requirements in 
terms of ethics and transparency, and it’s 
important to do research in a way where 
patients and the community know what’s 
going on and that participants consent 
with full knowledge.”
A prime challenge is putting 
together an information system that 
allows the medical community access to 
informatics in a way that is effective and 
well-organized. “There’s a lot of data and 
you need to query those data efficiently 
and manipulate it efficiently so the 
information is in a safe and cyber secure 
environment — that’s the trick,” says 
Keith A. Crandall, Ph.D., director of 
GW’s Computational Biology Institute 
in the Milken Institute School of Public 
Health. “We have an exceptional team 
working on this. From bioinformatics 
platforms to tool developers to data 
analyzers to cybersecurity experts and 
WORKFORCE DEVELOPMENT: Develop a new generation 
of diverse, high-quality, child health-focused clinical 
and translational research (CTR) investigators through 
educational, training, and mentoring programs.
COLLABORATION + ENGAGEMENT: Create unique 
approaches and technologies to catalyze CTR, particularly in 
child health, through novel cross‑disciplinary collaborations 
that engage multiple stakeholder communities.
INTEGRATION: Foster multidisciplinary teams capable 
of conducting child‑health CTR across the translational 
spectrum to address health disparities, fetal/maternal 
medicine, and rare genetic diseases.
METHODS + PROCESSES: Spark the development, 
evaluation, and dissemination of methods to enhance CTR, 
with an emphasis on the child‑health CTR spectrum from 
conception to adulthood.
INFORMATICS: Advance child‑health CTR through a 
comprehensive, integrated information ecosystem, with 
user‑friendly training in informatics methods and tools.
internet trafficking experts, we collaborated with the Division 
of Information Technology on this proposal because they know 
the ins and outs of data security and how to move data around 
from place to place efficiently and securely.”
FIELDING YOUR TEAM
Translational Workforce Development is another vital 
area, says Guay-Woodford. She compares it to choosing 
occupational therapists or psychotherapists to put on your 
research team. They can be a great asset, but it’s like asking 
a soccer player to make a game-day switch to baseball — the 
players are great athletes, but you need to show them how to 
play the game and give them the tools to succeed. 
Just as there are different positions with unique roles 
and responsibilities on the athletic field, the CTSI-CN is 
customizing on-demand training to different groups to match 
their needs. One example is training for clinical research 
associates; they need to become savvy about regulatory, billing, 
and data management issues. 
From Guay-Woodford’s perspective, if everybody on the 
team understands the game that is being played, what their role 
is, and what they need to do to work well together, you’ll end up 
with a winning team.
Amanda Kasper, M.P.H. ’09, director of operations for 
CTSI-CN, also likes how the award extends to a wide breadth 
of talent. “Educating and preparing the faculty reaches wide, to 
the nursing staff, clinical research staff, and beyond,” she says. 
“We want it to be across the workforce, using existing and new 
educational activities. A highlight is the number of internships 
being offered to scholars … to spend time in prestigious 
organizations and get hands-on experience is very valuable.”
PLAYING TO YOUR STRENGTHS
The award also allows for the individual CTSA program to 
choose a pair of optional modules on which to focus. Orphan 
product acceleration, or the development of treatment options 
for rare diseases, is something about which many of the 
researchers involved with CTSI-CN are excited. 
“We have a really strong history of drug development, 
particularly in the muscular dystrophy space and also pediatric 
device development,” Guay-Woodford says. The idea of this 
module was to provide an entry for an interested investigator 
to understand the steps needed to go down a path of drug 
development or device development, among them dealing with 
regulatory issues and business planning.
The other module, Child Health Research Acceleration 
through Multisite Planning, or CHAMP, focuses on how 
investigators from multiple institutions can work together on 
research and act on issues such as recruitment, ethics, and data 
collection. A team-building immersion boot camp to be held 
annually at the University of California Irvine, focuses on the 
CHAMP themes, such as building a team through intrastream 
communication and how a team operates together. 
Community involvement also remains an important 
feature of the CTSI-CN now that it’s shifted to the second 
version. A standout, Kasper says, is Science Café, a quarterly 
event held at Washington, D.C. staple Busboys and Poets, 
where community members participate in a discussion on 
medical topics. “It’s a chance to share research and help the 
community at large learn about a disease,” she says. “We’ve 
seen many people come to the event connected to the disease 
topic being featured in some way, [and] subjects have included 
sickle cell and asthma. The community engagement team 
works hard with the community to figure out their defined 
needs of what they want to learn about. Our advisory group of 
parents and community members are vital in giving us insight 
on possible programs for the community.”
LOOKING DOWNSTREAM
In a presentation to the SMHS Dean’s Council, Guay-
Woodford says one strength of the CTSA is the opportunity 
to cross-train researchers and clinicians. “We will help 
investigators build their databases, recruit their patients, 
design their studies, prepare their IRB proposal, run their 
studies, and help them with community outreach,” she said 
during the talk.
It’s early, but Kasper sees the second round of this 
partnership flourishing since the award was given in July, and 
she is optimistic about what’s coming next. “Downstream, 
you see the effects of the clinical trials that are going through, 
and you see the infrastructure moving innovations that much 
more,” she says. “This is a great fusion of two institutions 
combining strengths.”
With empowering assistance to the medical community, 
Miller believes this second five-year cycle has a chance to lead 
to an incredible period of prosperity. 
“So much of this builds through the community working 
together, but also among the CTSAs,” he says. “It makes us 
strong to have such a large number of people at the ready to 
share insights.”  
Just as there are different 
positions with unique roles and 
responsibilities on the athletic 
field, the CTSI-CN is customizing 
on-demand training to different 
groups to match their needs. 
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CANCER  
         MOVEON THE
GW Cancer Center Moves into 
New Collaborative Space Atop the 
Science and Engineering Building
BY KATHERINE DVORAK
The days of basic scientists laboring in virtual isola-tion in their labs in search of the next discovery are well in the past. In today’s research world, collaboration is key. That’s never been more evident 
than in the sparkling new facilities on the eighth floor of 
George Washington University’s (GW) newly built Science and 
Engineering Hall (SEH). The SEH reflects the importance of 
having a space dedicated to collaboration across disciplines. 
The facility, which spans 500,000 square feet, is the 
largest academic building dedicated to the fields of science and 
engineering in Washington, D.C., and the very top floor is now 
home to a growing number of cancer research labs run by GW’s 
School of Medicine and Health Sciences (SMHS). 
Having the space allows SMHS to broaden its research 
efforts, especially when it comes to cancer and translational 
science, says Edward Seto, Ph.D., associate center director for 
basic sciences at the GW Cancer Center (GWCC) and professor 
of biochemistry and molecular medicine at SMHS. 
Two areas of emphasis in the labs are cancer epigenetics 
and immunology and immunotherapy, says Seto, who provides 
leadership for the development, implementation, and evaluation 
of basic science–related programs and initiatives. He says scien-
tists will also dedicate research to microbial oncology, work that 
will be done with the help of the Department of Microbiology, 
Immunology, and Tropical Medicine. 
In addition, the space will better foster collaboration 
between students and researchers in both SMHS and the School 
of Engineering and Applied Science, Seto says. 
“A lot of non-scientists think research is [performed by] 
someone who’s doing experiments alone in the basement or 
garage,” he says. “But that’s not how science is done. Scientists 
have to work together, where they can bounce ideas off each 
other and work in groups to do things beyond each [person’s] 
expertise.” 
Every inch of the new floor, Seto goes on to say, “has been 
designed to promote collaboration and the exchange of ideas. 
With everyone working together, good ideas are bound to come 
out of it.” 
Currently, seven SMHS labs occupy the eighth floor. When 
the floor is completely filled, Seto expects to have between 12 
and 15 labs in the space. 
The floor also features 19 offices, 60 workstations, and 
common and meeting areas. It is outfitted with state-of-the-art 
equipment that will help researchers carry out their molecular 
biology, biochemistry, and cell biology work. In addition, the 
floor will house a new facility in which to perform patient-
derived xenograft model studies, a preclinical platform that will 
help predict the effectiveness of novel chemotherapeutics for 
cancer patients. 
Seto says the building and the eighth floor show GW’s 
commitment to advancing both science and engineering, a stra-
tegic goal of the institution.   
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AT THE CORE
Within the 500,000 square feet of the new Science 
and Engineering Hall (SEH), researchers and students 
from the George Washington University (GW) School 
of Medicine and Health Sciences (SMHS) are hard 
at work not only on the eighth floor, but also in 
other areas of the building, including a specialized 
Nanofabrication and Imaging Center (NIC), operated 
by the Office of the Vice President for Research.
The NIC is one of the most pristine areas on 
campus. It houses a class 100 cleanroom equipped 
with a full spectrum of nanotechnology equip‑
ment that will be used to create devices that are 
tens of nanometers in size in an environment free 
from contaminants. 
The neighboring microimaging suite is filled with 
modern microscopy instrumentation, allowing visual‑
ization of atomic structures, integrated microcircuits, 
neuronal circuits, and more. The advanced tools and 
technologies will allow researchers to study samples 
in ultra‑fine detail and allow them to create large 3‑D 
reconstructions of specimens.
For Anastas Popratiloff, M.D., Ph.D., adjunct 
associate professor of anatomy and regenerative 
biology at SMHS, combining all of GW’s microscopy 
resources under one roof is a great approach. 
“I believe in technology. I believe technology 
can change perceptions,” he says. “This is the kind of 
thing that’s going to move us forward.” 
The new labs and technologies allow for infra‑
structure that will expand the work and research GW 
does, he says. In addition, it encourages sharing of 
the equipment between students and faculty in the 
Columbian College of Arts and Sciences, the School 
of Engineering and Applied Science, and SMHS. 
“I think collaboration now is becoming more and 
more important,” Popratiloff says. 
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Brad Jones, Catherine Bollard, and Douglas Nixon were sitting around 
Bollard’s office one morning, bouncing ideas back and forth. Other 
“collaboratories” — teams of researchers and institutions united under 
a National Institutes of Health (NIH) grant with a goal of curing HIV/
AIDS — had devised clever, to‑the‑point names for their projects: 
CARE (Collaboratory of AIDS Researchers for Eradication), DARE 
(Delaney AIDS Research Enterprise), and the even more straightforward 
“defeatHIV.” The trio wanted to do their mission justice.
BY CAROLINE TRENT-GURBUZ
guess maybe a week before that, I was having a 
conversation with a friend of mine who’s living with 
HIV, who has followed the research very closely,” 
recalls Brad Jones, Ph.D., assistant professor of 
microbiology, immunology, and tropical medicine at the GW 
School of Medicine and Health Sciences (SMHS). “He said, in 
a moment of weakness, that he wasn’t sure if he believed there 
would be a cure for HIV.”
The word stuck with Jones. Believe. He played around 
with possibilities and was surprised at how easily he could 
create a spell-out for the acronym reflecting the goals of 
the collaboratory: “Bench-to-Bed Enhanced Lymphocyte 
Infusions to Engineer Viral Eradication.”
“Our program goes all the way from basic science to 
the bench to the bedside: We’re taking these lymphocytes, 
which is another word for immune cells, so-called T-cells, and 
enhancing them, putting them back into the patient, and trying 
to eradicate infection,” he says. “It just clicked.”
Best Science
The BELIEVE grant, as it’s now known, is a multimillion-
dollar grant awarded as part of the second iteration of the 
NIH Martin Delaney Collaboratory: Towards an HIV-1 
Cure. Established in honor of late AIDS activist Martin 
Delaney, the five-year grant is designed to draw researchers 
out of their silos, pairing them with colleagues across the 
country. The grant also puts researchers together with private 
companies, in this case immunotherapeutic company Altor 
BioScience Corporation (Altor) as well as Torque Therapeutics 
(Torque), a biomedical engineering company, to accelerate the 
bench-to-bedside process.
“Part of the fun of this [grant] was finding partners that 
we think are doing really exciting, cutting-edge studies with 
products that we hope could also be of value in the HIV cure 
area,” explains principal investigator Nixon, M.D., Ph.D., chair 
of the Department of Microbiology, Immunology, and Tropical 
Medicine and Walter G. Ross Professor of Basic Science 
Research at SMHS. “It’s something important, for us to be 
working with industry partners.”
It’s just as exciting, he adds, to find other researchers doing 
the “best science,” a critical aspect of the inclusive, cooperative 
nature of the grant. “I think one of the things about this sort 
of team-type science is that no one group has all the expertise 
necessary, so you actually welcome the opportunity to reach 
out and find the best people.” 
Driving the Research
To keep the research on track — and the communication 
flowing — the BELIEVE Executive Committee, composed 
of Nixon; Jones; Bollard, M.D., professor of pediatrics and of 
microbiology, immunology, and tropical medicine at SMHS; 
and Alan Greenberg, M.D. ’82, M.P.H., director of the D.C. 
Center for AIDS Research, and professor and chair of the 
Department of Epidemiology and Biostatistics at the Milken 
Institute School of Public Health at GW, will track progress 
among the teams.
“The way we’ve structured this grant, all of the different 
objectives have milestones and timelines that they need to 
meet,” explains Jones. If all of those milestones are met, the 
grant value could reach $28 million.
In essence, GW, in running the management and 
operations section, is the engine pulling the rest of the train. 
“Obviously,” Nixon adds, “you need all the parts to work 
together for a functioning unit. We have to keep all of our 
subcontracts in order, we have to keep the milestones on track, 
we have to have these compulsory meetings … we’ve got a lot of 
administrative components that are really important.”
Armed Against Infection
With GW leading the way, the BELIEVE grant has several 
initial research foci: enhancing the killing capability of 
HIV-specific T-cells, expanding the functions of natural killer 
cells, helping the killer cells find HIV in the body more easily, 
and bringing the best combinations into clinical studies.
“The overall idea is that the different foci come together 
to turn the immune system into a kind of weapon against the 
HIV reservoir,” explains Jones.
Although antiretroviral therapy can help reduce HIV levels, 
it cannot reach dormant, or hidden, HIV in the latent cells, 
which can reactivate and start the infection cascade over again. 
Previous researchers have used “kick and kill” strategies to try 
to eliminate infected cells, but their efforts have been limited, 
owing to the inability of the immune system to reduce the viral 
reservoir, or kill enough of the infected cells. The BELIEVE 
teams will use their expertise — and the products of Altor and 
Torque — to define the mechanisms that have prevented the 
immune system from completely clearing the infected cells.
Enhancing the T‑Cell 
The investigations at GW and clinical partner Children’s 
National Health System, led by Jones and Nixon, focus 
specifically on the grant’s first research target: making the most 
of the T-cell’s killing power.
“My goal is to figure out how we can best aim killer T-cells 
against HIV-infected cells,” says Jones. “[HIV cells] have ways 
that they usually hide from the immune system, but we want 
to expose them. Other people have strategies they’re working 
on to send these T-cells to the right parts of the body and to 
directly enhance the function of the T-cells, but I’m really 
working on how to direct them properly.”
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In other words, Jones is focusing more on the “kill” side of 
“kick and kill.” To accomplish his goal, Jones is working closely 
with Altor, which has developed a molecule known as ALT-803. 
This molecule reverses HIV latency in cells and, when given 
as a therapeutic, activates T-cells and natural killer cells 
throughout the body.
“What’s unique about Altor’s molecule is it actually wakes 
up hidden HIV and enhances the ability of the immune system 
to kill those reactivated cells, so we think it’s really unique and 
exciting,” explains Jones, adding that the company’s scientists 
also bring a great deal of enthusiasm and insight to the project. 
ALT-803 is currently in clinical trials for cancer, which makes 
establishing similar trials using the molecule for HIV/AIDS a 
faster, more efficient process.
Torque, on the other hand, has found a way to attach 
efficacy-enhancing drugs to cytotoxic T-cells via nanoparticle 
backpacks, a delivery method that can help the researchers 
precisely coordinate the “kick” with the “kill,” potentially 
leading to clearance of the HIV viral reservoir.
Jones is also focusing on a pair of preclinical systems. The 
first involves testing the cells of those living with HIV, in vitro. 
“We have assays that let us test different ways of eliminating 
HIV in the test tube,” he explains. “We need to pass certain 
milestones in that kind of controlled setting before we can 
expect to have success in the more complicated in vivo setting.” 
To connect the test-tube setting to patients, Jones and his team 
of investigators will use a unique mouse model as a stepping-
stone to the clinical phase.
Historically, small animal models have proven a tricky 
prospect for HIV researchers because mice cannot be infected 
with HIV; rather, researchers create “humanized mice,” or mice 
carrying a human immune system. Jones is taking a different 
tack: “We’re taking those immune cells from people who have 
been on antiretroviral therapy for years, and [we’re] putting them 
into mice, so you already have that natural HIV reservoir.”
Bollard’s work, meanwhile, is more translational. Her 
research “involves the manufacture of HIV-killing T-cells 
and the administration of these novel T-cells to HIV-positive 
individuals on antiretroviral therapy given either alone or in 
combination with the latency reversal agent ALT-803,” she says. 
“We will evaluate the safety of this combination and the efficacy 
of this therapeutic approach to clear the viral reservoir.”
She will base the HIV-killing T-cells she’s developing on 
the work Jones is conducting in the mice. Then, they’ll give 
those cells to patients.
“What’s unique about this grant is the rapid translation 
of novel ideas developed at the bench and then getting them 
to the clinic,” she says. “So much work is done that is focused 
on the mice or the monkey, and [it] never gets any further. It is 
refreshing to see such an emphasis on translation to the clinic.”
For Nixon, Bollard and Jones’ work exemplifies the greater 
goals of the grant. “We have an ambitious program in which we 
would like to be able to move into the clinic in Year Two,” he 
says. “We’ll have to see if that’s a possibility, but we’re certainly 
going to try and push for that. Our philosophy is best science 
plus getting into the clinic as rapidly as possible.”
Broader Conversations
Outside the labs, the grant will prioritize community engagement 
through local advisory boards and ongoing communication.
“[It’s not] just teaching the community, [it’s] listening to 
people’s expectations about cure research, their fears, their 
hopes, so that we can be sure that we’re responsive to the 
people that we’re trying to help,” explains Jones.
Washington, D.C., in particular, has had some of the 
highest rates of HIV in the nation, according to Greenberg, 
and the grant helps establish the nation’s capital as “one of the 
focal points for NIH-supported HIV cure research,” he says, 
which is vital for the community.
Working with the community will also help the team 
address misconceptions about what a cure could look like; 
taking a pill or two, Jones says, is not yet on the horizon. 
What is available now, however, are the highly customizable 
procedures that the BELIEVE grant is pursuing. “There are 
a lot of approaches, like ours, that involve donating cells that 
are manipulated and then reinfused into individuals,” he 
says. “We want to be responsive to the community to make 
sure that in their perspective, the cures that we develop are 
a significant improvement over the current option, which is 
daily antiretroviral therapy. We want to make sure that we’re 
engaging in a dialogue at all steps of the process.”
With that conversation in mind, Jones adds that his friend, 
representative of the community, isn’t quite a believer — yet. 
“He does [know about the grant and the work we’re doing],” 
says Jones. “He’s quite touched that his comment became part 
of this large effort.”  
“We want to be responsive to the community to 
make sure that in their perspective, the cures that 
we develop are a significant improvement over the 




DATA IS BEING 
COLLECTED ALL 
AROUND US, AND 
WE KNOW IT. 
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BY ERIC BUTTERMAN
BIG
which society is generating between 
two and three exabytes of information 
daily. To put that into perspective, 
your top-of-the-line laptop might 
boast 500 gigabytes, or half a terabyte, 
of hard drive space; an exabyte is 1 
million terabytes.
For Raja Mazumder, Ph.D., 
associate professor of biochemistry and 
molecular medicine at SMHS, what 
big means is beautiful. “Most of the 
time with big data, there are certain 
technologies such as next-generation 
sequencing, which produces a lot of data. 
But how much data? I heard in a talk that 
conceptually it costs millions of dollars 
to put a satellite into orbit producing 
x amount of data, but it doesn’t cost 
millions of dollars to purchase a 
sequencing machine to generate an 
equivalent amount of genomic data.”
And, when it comes to the medical 
field, where the data is coming from 
isn’t the question. It’s really where isn’t it 
coming from.
“It’s practically all over,” Mazumder 
says. “Some of it still is coming 
the old-fashioned way — a health 
practitioner inputs medical information 
— but quite a bit is being generated by 
medical instruments working directly 
with software generating a vast amount 
of genomic data, for example.”
GETTING 
“INFORM”ED
At the core of big data in medicine are 
two vital disciplines, bioinformatics 
and medical informatics. Let’s start 
with bioinformatics. 
“Bioinformatics, in our area at the 
school, is dry lab technology, which 
means we analyze biomedical and 
biology-related data and use algorithms 
to analyze it and come up with methods 
to process, store, and compute it,” 
explains Mazumder. “And we share the 
data and define security [protocols] to 
even work with it.”
Mazumder co-directs the HIVE 
project, which stands for High-
performance Integrated Virtual 
Environment, a collaboration between 
his group and the U.S. Food and Drug 
Administration. The project is a dynamic 
cloud system for bioinformatics sequence 
data analysis focused on harnessing 
next-generation data sequencing; more 
recently, his group has also been working 
on proteomic data analysis. 
In fact, multiple bioinformatics 
projects at GW focus on trying to 
standardize computations. “Standardized 
means, for example, you have a vaccine 
sample and you are producing that 
vaccine in your company all the time,” 
Mazumder says. “But how do you know 
from Batch 1 to Batch 2 that you still have 
just the vaccine and that contamination 
hasn’t occurred? Once you analyze 
[gene-sequence data], then you can say 
in a particular sample that you have the 
all-important pure culture of vaccine and 
no mutations that are detrimental.”
The biggest challenge for next-
generation sequencing data analysis is the 
ability to scale up. This issue can come 
into play if, for instance, a patient has the 
hepatitis C virus and you want to know 
the genotype of that virus, Mazumder 
explains. Determining the genotype can 
be difficult because in the case of hepatitis 
C, the illness is chronic; it can create 
subclones of viruses in a patient, and the 
It’s happening at the checkout line when 
we get that discount for using our grocery 
store rewards card — and the store is 
learning our preferences in return. 
Health care services may not be 
marketed to us the way products in the 
grocery store are, but a mountain made 
up of medical records has appeared 
in the virtual world, and it’s growing 
exponentially every year. At the core of 
that mountain runs a rich vein waiting to 
be unearthed — medical data — and that 
digital ore offers all of us the chance for a 
healthier future.
Important big data contributors 
at GW School of Medicine and Health 
Sciences (SMHS) are looking to mine 
that data and refine it into a most 
precious resource: innovation.
DEFINE BIG
Big data is a techno-term that frequently 
gets tossed around. But what is big 
data exactly? How big is big? With the 
expansion of technology into our daily 
lives, whether it’s our smartphones; 
the radio-frequency ID tags that track 
our packages, our pets, and more; 
genomic data; or our electronic medical 
records, information is piling up at a 
dizzying pace. According to computing 
giant IBM, we’ve reached the point at 
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same patient can be infected more than 
once in a lifetime. “Sequencing the virus 
from one patient one time isn’t tough, 
but when you get 50 to 100 samples, the 
computers and the algorithms available 
are not sufficient and, therefore, they 
require scaling up,” he says.
In other words, as researchers move 
to the high-throughput sequencing 
machines, the amount of data produced 
can be huge. 
“With the bioinformatics we’re 
specifically working on — if, say, a 
patient has a mutation in position 53 in 
a specific protein, so what?” Mazumder 
says. “But the hope is that if we can have 
additional pieces of information through 
complementary discipline. 
“There are many definitions, but 
the gist of medical informatics is that 
it’s about using information technology 
to improve medical research, medical 
care, and health care delivery; basically 
applying data science, information 
science, and technology to improve 
health care,” says Zeng. “We use 
information science and computer 
science methods to improve aspects of 
the biomedical research or biomedical 
science, even clinical research.”
The amount of data to choose from 
is practically equivalent to the raindrops 
in an endless monsoon. 
“You have to be amazed at all the 
that you just don’t see in a clinical trial … 
When looking at medical records, you 
can go back 15, possibly even 30 years.”
The numbers say medical 
informatics’ reach looks to be expanding. 
According to the 2014–24 projections on 
the Bureau of Labor Statistics website, 
medical records and health information 
technicians will see 15 percent growth in 
employment. “We’re just at the start of 
what can be done,” Zeng says.
In the end, how do medical 
informatics and bioinformatics best 
complement each other? “I think what 
will happen is hospitals will start having 
their own databases of genomic sequence 
data,” Mazumder says. “Then, the 
comprehensive data integration for the 
hepatitis C virus, then we can say that 
this position codes for this protein and 
there is already a drug that targets that 
mutation. And if you have that, now 
you have actionable information from 
a research perspective. And then … you 
can look at a treatment perspective.”
COMPLEMENTARY 
COMPUTING
Yet there’s still that other major 
player to consider in big data: medical 
informatics. Some may view it as a rival 
to bioinformatics, competing interests 
in a battle for health information. 
Medical informatics, to Qing Zeng, 
Ph.D., professor of clinical research and 
leadership at SMHS, isn’t a competitor 
to bioinformatics but rather a potential 
data available for medical informatics,” 
Zeng says. “It’s the collection for routine 
clinical trial patients, it’s the medical 
record, and even a biosample collected.”
One form that medical informatics 
has taken at SMHS is the Otsuka Data 
Mining project. “Otsuka is a company in 
the pharmaceutical space,” she explains. 
“They were interested in psychiatric 
disease and wanted us to look at aspects 
such as schizophrenia and bipolar 
disease [to predict outcomes].”
The team identified more than 
1 million patients who fit the criteria 
they were focusing on. “Remember that 
clinical data tends to be more diverse 
than clinical trial data because [patients 
in the latter group] tend to be younger 
and healthier,” Zeng says. “We do a 
retrospective analysis on data sets and 
can pick a large amount of information 
medical informatics data will not only 
use electronic health records, it will use 
genomic health data that is continuous.”
RESPECT  
THE PATIENT 
Still, when you combine a seemingly 
nonstop pipeline of statistics and 
something as personal as health 
information, there is risk. “I think we 
will see some changes in years to come 
in how patients have access to data, that 
they have access and can do what they 
want with data,” Mazumder says. “My 
perspective is I think the data should 
belong to the patient. We need to make 
strides, but we have to remember, at the 
least, the dignity of the patient and a 
sensitivity to what these statistics mean 
to them.”  
“ WE’RE JUST AT THE 
START OF WHAT CAN 
BE DONE,” ZENG SAYS.
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C
arolina Panico, M.D., Ph.D., laughs as she describes telling 
her father she had become an American citizen. “I called my 
dad, I told him, ‘Dad, I’m an American today!’ and he said, 
‘You were American before.’” 
Panico, a native of Naples, Italy, originally came to the United 
States during her Ph.D. program, when she was a student at the 
Second University of Naples. “I had the chance to come to the 
States to visit Georgetown University,” she says. “After my visit, the 
director of the laboratory in the Department of Nephrology there 
became my co-mentor for my Ph.D. thesis.” 
Panico conducted most of her research in renal and 
cardiovascular pathophysiology at Georgetown University, where 
she stayed until moving across town to work in the Department 
of Biochemistry and Molecular Medicine at the GW School of 
Medicine and Health Sciences (SMHS). It was there that she 
started exploring regulatory affairs. 
“I heard about the regulatory affairs [program at GW] 
because this has become one of the hot topics in the last few years,” 
she says. “It sounded very exciting to me, and I applied, and I was 
accepted.” 
The program was a good fit: “It integrates elements of 
global regulatory strategy across the entire curriculum, and 
you get an understanding of the regulation for the development 
of [a] spectrum of products, like drugs, devices, biologics,” she 
explains. “Also, you acquire the ability to work in an international 
environment, which is very important to me.” 
The program also offered Panico insight, she says, into areas 
somewhat neglected during traditional education: entrepreneurial 
thinking and the rules and regulations of medicine development. 
The latter allowed her to gain greater understanding of the bench-
to-bedside process, while the former is opening up new potential 
career options — possibly sooner rather than later. 
“I have some very good news,” Panico announces. “There 
is a fellowship I applied to, the Federal Drug Administration 
Commissioner’s Fellowship, which is in regulatory science, and I 
actually was selected.” 
Panico attributes her selection for the fellowship directly to 
her experience in the SMHS Regulatory Affairs program; she was 
able to meet with several experts through GW, and her most recent 
classes, she says, helped her perform well during the interview. 
The fellowship will keep her in the Washington, D.C. area, 
and although she continues to miss her family and best friends in 
Italy, she has found one bright spot in the city that has become her 
home: a Neapolitan pizza place in her neighborhood. 
“There are great places now where you can eat very good 
Neapolitan pizza; there’s one in Takoma Park especially,” she says. 
“I’m a little picky about my pizza.”  
FROM ITALY TO AMERICA
BY CAROLINE TRENT-GURBUZ
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Stephanie Cho’s office, at the end of a long, U-shaped corridor, is calm and soothing. She speaks enthusias-tically about her profession — she’s a PGY IV chief resident in psychiatry at the GW School of Medicine 
and Health Sciences (SMHS) — and her goal is clear: to treat 
those in need. 
“I knew from a young age that I wanted to be a doctor,” 
Cho recalls, settling into a chair near her desk. The daughter of 
Korean immigrants, she grew up in the suburbs of Los Angeles. 
When she was younger, her father suffered from heart problems, 
an experience that “sparked [her] interest in medicine.” 
In pursuit of the “best science education” she could get, 
Cho moved from coast to coast: first, to the Massachusetts 
Institute of Technology (MIT) and then, following graduation, 
back to southern California, where she earned her M.S. and 
M.D. degrees from Loma Linda University. Now, she’s nearing 
the end of her psychiatry residency at SMHS, and her next step 
is a fellowship in psychosomatic medicine. 
“Psychosomatic medicine … is basically psychiatry [for] 
the medically ill,” she explains. More specifically, the discipline 
connects psychological and behavioral factors with their impact 
on health and disease. “That brings it all together for me,” says 
Cho. “As I went through medical school and residency, I realized 
that this is what I always pictured as being a doctor: being aware 
of a patient’s medical problems and how they are affecting their 
life and the quality of life they have. 
That’s what I’ve begun focusing more and 
more on throughout residency.” 
That kind of focus — how someone’s 
health, mental or physical, affects quality 
of life — goes back to her early days at 
MIT, when she was rushing a sorority. 
“One thing that I realized when I went 
through the recruitment process was 
it’s a really a stressful situation; you’re 
being put into a social situation where 
you’re not judging each other, but you’re 
trying [to find] a really great fit,” she says. 
“Especially in the beginning of college, in 
that age of adolescence, it becomes very 
much about, ‘Am I good enough? Do they 
like me?’” 
Cho, who joined Alpha Chi Omega, 
became a recruitment counselor and 
reached out to MIT mental health. Together, they brought 
in psychiatrists and therapists to train counselors on how 
to help students process what could be an emotionally 
grueling experience. 
A few years later, as part of a clerkship, Cho helped another 
group of students deal with a potentially draining undertaking: 
treating addiction patients with empathy. “This was very 
interesting to me in general, because it’s not just psychiatrists 
who deal with it; really, all physicians need to address addiction 
in their patients,” she explains. What she found was that 
medical students tended to be more empathetic to certain 
subsets of patients, such as veterans. With patients who grew 
up in more privileged environments, medical students were 
actually less empathetic. Cho is now working on a project to 
help address how students feel or don’t feel empathy toward 
patients with psychosomatic illnesses. 
“I feel very strongly that all doctors should have [empathy] 
cultivated in them and really developed in them as they go through 
medical school — and be allowed to identify and be honest about 
it when they don’t feel empathy,” she says. “[It’s about] really being 
able to allow us as physicians to identify and maintain a strong 
sense of empathy without letting it drown us at the same time.” 
Cho plans to continue shaping empathy in all medical 
students, particularly when it comes to psychiatry. “I want to 
become a clerkship director and teach psychiatry to medical 
students,” she says. 
As she explains, she doesn’t want to “preach to the choir”; 
she wants to make sure every student, regardless of future 
specialty, feels comfortable addressing patients’ psychiatric 
needs. “Being able to give students that tool kit, to recognize 
their own levels of empathy and be able to address that to help 
people, that is what I want to do,” she says.  
The One Who 
Understands
BY CAROLINE TRENT-GURBUZ
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I can truly say that I had some great 
times this year #gwmed 
121 WEEKS AGO
M
arcus Mitchell, clad in green scrubs and his GW 
School of Medicine and Health Sciences white coat, 
has only a short break after finishing his rounds at 
GW Hospital to talk about the meandering path 
he’s taken in medicine. 
The D.C. native and fourth-year M.D. student initially 
planned on pursuing emergency medicine, but “although I have 
so much respect for the field, I quickly found out that it wasn’t 
for me,” he says, laughing. “Had you told me I’d be applying to 
anesthesiology last year, I probably wouldn’t have believed you. 
It’s something that just kind of developed.” 
Anesthesiology, he explains, pausing to sip from his to-go 
coffee, is procedural and hands-on, with moments of intensity. 
It incorporates pharmacology and physiology, which appeals 
to him, and it allows him to interact more closely with his 
patients, giving them his undivided attention. “I like that even 
though [during] your interaction with your patients, their 
conscious awareness is brief, it’s really powerful, especially 
during the pre-op encounter.” 
That kind of interaction is central to Mitchell’s brand of 
medicine: He cares about his patients, about his community, 
and about his future clinician colleagues. “I want to be 
involved with and serve an underserved community; that’s 
really important to me, that I have diverse patients who come 
from all over and have various socioeconomic statuses,” he 
explains. Already a veteran of medical mission trips to Haiti 
and Ecuador, Mitchell plans to bring his anesthesia skills to 
wherever they’re needed most. 
And at home, he plans to give back. When Mitchell 
first entered SMHS, he was awarded the Power and Promise 
scholarship, designed to alleviate the financial burdens 
for GW’s best and brightest. It’s helped relieve his student 
debt — and inspired him. “It actually encourages me to 
give back as an alumnus,” he says. “I definitely want to have 
my own scholarship fund so I can give back and help some 
[unsuspecting] student who’s doing a good job.” 
With that, Mitchell stands up, coffee cup still in hand, to 
head back to the hospital, where he’ll remain on call until 9 a.m. 
the next day.   
First operation of MS3 was a success! 
59 WEEKS AGO
BY CAROLINE TRENT-GURBUZ
The Power  
and Promise 
of Medicine 
The fam. #gwmed #blackmeninmedicine 
75 WEEKS AGO
Fourth‑year M.D. student Marcus 




Asthma in children living in the inner 
city can be especially severe, and 
research by Stephen Teach, M.D., 
M.P.H., chair of the Department of 
Pediatrics at Children’s National Health 
System and professor of pediatrics 
and emergency medicine at the 
GW School of Medicine and Health 
Sciences, shows there are distinct 
subgroups of asthma patients within 
that vulnerable population. 
Funded by the National Institutes 
of Health, the Inner‑City Asthma 
Consortium (ICAC), of which Teach 
is a member, consists of a group of 
investigators from across the country 
that focuses on improving outcomes 
for inner‑city kids with asthma. After 
a year of observing more than 600 
such children, Teach and his ICAC 
colleagues were able to identify five 
distinct asthma phenotypes. 
The phenotypes found were 
lower allergy/inflammation with 
minimal asthma symptoms, which 
affected 15 percent of participants; 
The Heart–Brain 
Connection
Between the heart and brain lie a 
series of connections — sometimes 
figurative, in this case literal — that 
researchers believe are the key 
to helping the millions of patients 
who suffer from heart failure. David 
Mendelowitz, Ph.D., vice chair and 
professor in the Department of 
Pharmacology and Physiology at the 
GW School of Medicine and Health 
Sciences, and Matthew Kay, D.Sc., 
associate professor in the Department 
of Biomedical Engineering at the GW 
School of Engineering and Applied 
Science, will examine that connection, 
thanks to a four‑year, $1.6 million grant 
from the National Heart, Lung, and 
Blood Institute.
The two will study ways to restore 
parasympathetic activity — which 
is cardiac protective — to the heart 
through oxytocin neuron activation, 
which could improve cardiac func‑
tion during heart failure. Heart failure 
affects both neurologic and cardiac 
function; Mendelowitz will focus on 
the neuroscience behind heart failure, 
whereas Kay will use high‑speed 
optical assessments of heart function 
to identify how oxytocin nerve activa‑
tion benefits the heart.  
highly symptomatic asthma (even 
with treatment) and lower allergy 
and inflammation, which affected 
15 percent; minimal asthma and hay 
fever symptoms, with intermediate 
allergy and inflammation, which 
affected 24 percent; higher asthma 
and hay fever symptoms and allergy 
inflammation, which affected 30 
percent; and the most symptomatic 
asthma with the highest serum lgE, 
blood eosinophil count, and allergen 
sensitizations, which affected 
16 percent. 
“For the first time, we’ve been 
able to describe in very elegant, very 
complete fashion various subgroups 
within this population, and going 
forward, these subgroups are likely 
to guide studies of targeted therapy,” 
Teach said. 
The findings were published 
recently in the Journal of Allergy and 
Clinical Immunology, along with two 
other studies by ICAC researchers on 
inner‑city pediatric asthma.  
Take a Breather
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Section Selection 
Pedro A. Jose, M.D., Ph.D., professor 
of medicine and of pharmacology and 
physiology at the GW School of Medicine 
and Health Sciences, was elected to 
serve as chair of the Hypertension and 
Microcirculation Study Section at the 
National Institutes of Health (NIH). 
The study section reviews grant 
applications involving basic and applied 
aspects of cardiovascular regulation 
with a focus on microcirculation, the 
pathogenesis of hypertension, and the 
physiology of blood pressure regulation. 
Jose, in his role, will facilitate the review 
process, which includes summarizing 
the grant reviewers’ discussion and 
calling for a final vote to determine the 
reviewers’ opinion regarding the scien‑
tific impact of the grant proposal. Once 
the grant proposals are reviewed, the 
appropriate council conducts a second 
round of reviews, and a recommendation 
is sent to the NIH for a final decision. 
Jose previously served as chair of 
the Hypertension and Microcirculation 
Study Section from 1996 to 1998, when 
it was known as the Cardiovascular and 
Renal Study Section B. The scope of the 
study section has since narrowed.  
With a pair of grants totaling more than 
$1 million, the George Washington 
University Cancer Center (GWCC) 
continues to advance health equity 
across the Washington, D.C. area. From 
the Pfizer Foundation, GWCC received 
$1 million to promote patient‑centered 
cancer care and increase patient health 
literacy and cultural sensitivity. The 
project, which provides resources for 
patients and health care providers 
to have improved conversations, will 
examine how gender, gender identity, 
race, ethnicity, sexual orientation, and 
income affect the patient–provider 
Excellence in Care 
John Larsen, M.D., professor of obstetrics and gynecology and former chair of the 
department at the GW School of Medicine and Health Sciences, recently marked 
his decades‑long career with a prestigious award: the 2016 Hellman Midwifery 
Partnership Award. Larsen, who has been a fellow of the American College of 
Gynecology (ACOG) since 1976, received the ACOG recognition for having 
demonstrated outstanding support for midwifery through advocacy for 
women; excellence in clinical, education, and research endeavors; and 
leadership in collaborative practice. Larsen has played a leading role in 
integrating midwifery care into GW Hospital, and he helped expand 
access to evidence‑based comprehensive care. 
The award is jointly sponsored by the American College of Nurse 
Midwives (A.C.N.M.), the A.C.N.M. Foundation, Inc., and the Midwifery 
Business Network.  
relationship. 
The second grant, $100,000 
from Susan G. Komen, given as part 
of a local investment of more than 
$1 million, will fund a multifaceted 
project designed to reduce cancer 
disparities in the lesbian, bisexual, 
and transgender (LBT) community 
in Washington, D.C. The goal of the 
project is to increase LBT individuals’ 
health literacy and engagement in 
health care and help health profes‑
sionals provide more sensitive care to 
LBT patients at risk of or diagnosed 
with breast cancer.  
Health Equity and Cultural Sensitivity
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FACULTY NEWS
THE CAMPAIGN FOR GW
SCHOOL OF MEDICINE &
HEALTH SCIENCES
Support the School 
of Medicine &
Health Sciences
By advancing our four-part mission — to teach, 
heal, discover, and serve — George Washington 
University‘s (GW) School of Medicine and Health 
Sciences (SMHS) seeks to change lives for the better. 
As part of GW’s $1 billion philanthropic campaign 
— which supports students, enhances academics, 
and breaks new ground through capital projects 
and research — your gift enables SMHS to make a 
positive impact in the community, the country, and 
the world.
Join us in making history
go.gwu.edu/makehistorysmhs
Capital campaign.indd   1 10/13/16   11:57 AM
Ian Toma, M.D., Ph.D. ’11, M.S.H.S. 
’04, associate research professor 
of clinical research and leadership, 
and of medicine at the GW School 
of Medicine and Health Sciences 
(SMHS), was selected as a Core 
















with the State University of Medicine 
and Pharmacy of Moldova (SUMPH) 
to develop an educational program 
in bioinformatics and genomics for 
medical students, residents, and 
local scientists. By developing this 
program, Toma will not only help 
raise the capacity of SUMPH in this 
area, but also foster the collabo‑
ration of students, faculty, and 
scientists with SMHS and other 
international partners.
Toma will also initiate a joint 
SUMPH/SMHS research collaboration 
between faculty and scientists on 
genomic aspects of tuberculosis (TB) 
and its multidrug resistant (MDR‑TB) 
forms. The project, titled “MDR‑TB 
Results from Unmasking of Resistant 
Strains from the Total Mycobacteria 
Population by Antibiotics,” will look at 
the genomic profiles of patients diag‑
nosed with TB and strains isolated 
from patients in Moldova. The goal of 
this research is to create an accurate 
and simple genomic test to deter‑
mine how the patients respond to 
treatment and whether patients are at 
risk of developing the MDR‑TB forms, 
which are often missed and hard 
to diagnose.  
Teaching and Tuberculosis 
A Culture of Collaboration 
Gaetano Lotrecchiano, Ed.D., Ph.D., 
assistant professor of clinical research 
and leadership and of pediatrics at the 
GW School of Medicine and Health 
Sciences (SMHS), is spearheading a 
new seminar, “Creating a Culture of 
Collaboration at George Washington 
University,” or C3@GW. The seminar 
brings together a cross‑disciplinary 
community of GW expert faculty with 
an interest in scientific collaboration 
and connects them to regional and 
national partners and experts. 
Elements of C3@GW include “think 
tanks,” or communities representing 
GW, local institutes, and federal 
government stakeholders, as well 
as short‑ and long‑term discussions 
emphasizing the mechanisms of scien‑
tific collaboration: developing and 
educating team scientists; measuring 
team effectiveness; technologies for 
collaboration and scholarship informet‑
rics; organizational supports; faculty 
reward and recognition for collab‑
orative activities; and issues crossing 
cultural, ethnic, and gender boundaries 
in science. 
C3@GW is a collaborative venture 
with the Clinical and Translational 
Science Institute at Children’s National 
Health System, the SMHS Department 
of Clinical Research and Leadership, 
and additional experts from the GW 




Henry Kaminski, M.D., chair of the 
Department of Neurology and 
Meta Amalia Neumann Professor of 
Neurology at GW School of Medicine 
and Health Sciences, has found that 
removing the thymus effectively 
reduced myasthenia gravis (MG) 
patients’ muscle weakness, as well as 
the need for immunosuppressive drugs 
and hospitalizations. 
“While surgery is expensive and 
not without risk, this research will 
empower patients and their doctors 
to make informed decisions regarding 
treatment,” said Kaminski. 
Previous studies have suggested 
that removing the thymus may reduce 
MG symptoms — droopy eyelids; 
blurred or doubled vision; difficulty 
talking, breathing, and swallowing; 
and neck and limb movement 
problems — but Kaminski’s study, 
published in the New England Journal 
of Medicine, is the first randomized 
study of thymectomy in MG patients, 
providing clinical evidence of the 
benefits of the surgery.  
Leading the Charge 
Sally A. Moody, Ph.D., professor and 
interim chair of the Department of 
Anatomy and Regenerative Biology 
at the GW School of Medicine and 
Health Sciences, is on the rise: She was 
recently elected to a two‑year term as 
vice president, and later president, of 
the Society for Craniofacial Genetics 
and Developmental Biology (SCGDB). 
Moody, who has held leader‑
ship positions both internally at GW 
and externally, including serving as 
program official in developmental 
genetics and genomics at the National 
Institutes of Health – Eunice Kennedy 
Shriver National Institute of Child Health 
and Human Development, will bring 
invaluable experience to SCGDB. The 
international organization, established 
in 1975, is committed to advancing 
the knowledge, health, and preven‑
tion of craniofacial disorders through 
education and research. The goal of 
the organization is to decrease the 
incidence of birth defects affecting the 
craniofacial region. 
Moody was also part of a team of 
researchers whose study, “Label‑free 
Quantification of Proteins in Single 
Embryonic Cells with Neural Fate in the 
Cleavage‑Stage Frog (Xenopus laveis) 
Embryo Using Capillary Electrophoresis 
Electrospray Ionization High‑Resolution 
Mass Spectrometry (CE‑ESI‑HRMS),” 
was featured on the cover of Molecular 




Eduardo M. Sotomayor, M.D., 
inaugural director of the George 
Washington University Cancer Center, 
was elected to serve on the board 
of directors of the Association of 
American Cancer Institutes (AACI). 
Sotomayor began his three‑year term 
in October 2016.
The AACI comprises 95 leading 
cancer research centers in North 
America — including National 
Cancer Institute (NCI)‑designated 
cancer centers and academic cancer 
research programs that receive 
NCI support.
Sotomayor was elected to 
this prestigious group along with 
Karen Knudsen, Ph.D., B.S. ’91, who 
is the third director of the Sidney 
Kimmel Cancer Center at Thomas 
Jefferson University in Philadelphia, 
an NCI‑designated cancer center 
since 1995.  
Taking Aim at New 
Targets for Myasthenia 
Gravis Treatment 
Linda Kusner, Ph.D., associate research 
professor in the Department of 
Pharmacology and Physiology at 
GW’s School of Medicine and Health 
Sciences, received a multi‑year Muscular 
Dystrophy Association research grant 
of nearly $300,000 to provide a new 
fundamental understanding of the basic 
mechanisms of autoimmunity and to 
Salute to Sarani
Babak Sarani, M.D. ’97, associate 
professor of surgery at the GW School 
of Medicine and Health Sciences, 
has completed a neat hat trick: three 
awards in three years. In 2014, Sarani 
was the faculty inductee for the Gold 
Humanism Honor Society, which recog‑
nizes those who have demonstrated 
excellence in clinical care, leader‑
ship, compassion, and dedication to 
service. The next year, Sarani, chosen 
by third‑year medical students, earned 
the Golden Apple Award for Teaching 
Excellence. This year, he was selected 
by the members of the Emergency 
Medicine Residency Class of 2016 as 
the recipient of the Residents’ Choice 
Award, Off‑Service Attending of the 
Year, for trauma surgery.  
validate a new therapeutic target for 
myasthenia gravis (MG). 
Kusner aims to develop a therapy 
for MG that might lessen or eliminate 
the need for corticosteroids, the current 
standard of care. With colleagues, she 
discovered a protein called survivin 
present in MG‑affected cells that the 
group believes supports the pres‑
ence of autoreactive immune cells by 
allowing them to escape cell death. 
In studies that targeted the protein, 
Kusner and her team observed a reduc‑
tion in the levels of antibodies in the MG 
disease process. 
In her new work, Kusner will analyze 
thymus tissue from MG patients as well 
as from healthy individuals to deter‑
mine whether the survivin protein is 
present in both. Kusner’s team also will 
evaluate survivin‑based therapeutics 
in an MG rodent model to assess the 
therapeutics’ ability to improve observ‑
able weakness, decrease the expression 
of autoreactive immune cells, decrease 
acetylcholine receptor‑specific anti‑
bodies, and decrease damage to the 
nerve–muscle junction.  
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T-Cell Exhaustion and 
Toxoplasmosis
New research critical to treatment 
for chronic toxoplasmosis, one of 
the most common parasitic diseases 
worldwide, was published in the 
Journal of Experimental Medicine. 
A team of researchers from the 
GW School of Medicine and Health 
Sciences, led by Imtiaz Khan, Ph.D., 
professor of microbiology, immu‑
nology, and tropical medicine, 
identified a connection between 
CD8 T‑cell exhaustion and CD4 T‑cell 
exhaustion. They also determined 
that CD4 T‑cells can be regulated 
by Blimp‑1 protein expression. The 
discoveries could lead to new treat‑
ment possibilities. 
Toxoplasmosis is a parasitic infec‑
tion that in healthy adults does not 
typically cause symptoms. Among 
pregnant women and the immunosup‑
pressed, however, the consequences 
can be severe. This disease is especially 
Researchers from the GW School of 
Medicine and Health Sciences (SMHS) 
received a $2.1 million U01 grant from 
the National Institutes of Health to 
launch a Phase 1 clinical trial to test a 
new hookworm vaccine in Brazil. This 
effort is the latest in a series of tropical 
vaccines created by SMHS researchers. 
This clinical trial — led by co‑prin‑
cipal investigators Jeffrey Bethony, 
Ph.D., professor of microbiology, 
immunology, and tropical medicine 
at SMHS, and David Diemert, 
M.D., associate professor of 
microbiology, immunology, 
and tropical medicine 
at SMHS — will be the 
first time immune 
interference has 
been tested using 
new antibody profiling methods and 
B‑cell immunology. 
“We have two separate vaccines 
for hookworm that have each been 
tested on their own,” said Diemert. 
“We would like to combine them into 
a single product, so we have one vial 
offering the greatest protection against 
hookworm.”
A parallel clinical trial, funded by 
the European Commission, is underway 
in Africa; in this trial, all volunteers 
have been given both vaccines. In 
Brazil, some volunteers are given 
one of the vaccines, and others are 
given both vaccines, creating greater 
opportunities for comparison. For the 
clinical trial, GW is partnering with 
the Fundação Oswaldo Cruz in Brazil, 
University of California–San Francisco, 
and Johns Hopkins University, as well 
as the Sabin Vaccine Institute.  
Support for Hookworm Vaccine Trials
prevalent in HIV/AIDS populations. 
The study, titled “Blimp‑1 
Mediated CD4 T‑Cell Exhaustion 
Causes CD8 T‑Cell Dysfunction During 
Chronic Toxoplasmosis,” is funded by 
a grant from the National Institutes 
of Health. 
Khan recently received the SMHS 
Distinguished Researcher Award for his 
work on toxoplasmosis.  
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There are many options for donating your home, second home, commercial building, raw land or other 
real estate to GW. Depending on the nature of your gift and your objectives, you could:
• Avoid capital gains taxes on appreciated property
• Eliminate the burden of maintaining and paying for the property
• Provide yourself with an annual income
• Continue to use the property for the remainder of your life
• Reduce your estate and income taxes
Please contact us to discuss the benefits of a real estate gift for your specific situation.
Turn your Deed into
A GOOD DEED
DAR2860
The George Washington University
Office of Planned Giving – Real Estate
2033 K Street, NW, Suite 300
Washington, DC 20052
For more information, please contact:
Adam Lewis
Senior Associate Director of Planned Giving
202-994-7657 or aslewis@gwu.edu
Prior to acceptance of each potential gift of real estate, the University’s Gift Acceptance Committee reviews the administrative and 
financial costs, liabilities, and benefits of the gift. This review assures the George Washington University Board of Trustees that the gift 
advances the university’s mission and values and that it is financially sound.
If you want to create a lasting legacy at the GW School of Medicine and Health Sciences, 
consider a gift of real estate. Your donation can support medical student scholarships, 
advance powerful research initiatives, or provide valuable funding for community or education 
programs. What’s more, by donating real estate to GW, you can achieve peace of mind and 
receive significant financial benefits for yourself or someone else.
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W hen Milwaukee, Wisconsin, native Heather Levin, M.D. ’15, starts talking about research, her enthusiasm and delight builds, and it’s clear how much the work means to her. 
“It’s really exciting for me to have this research year,” 
she explains. 
Levin, with help from primary investigator Lopa 
Mishra, M.D., director of the Center for Translational 
Medicine and professor of surgery with the GW School 
of Medicine and Health Sciences, applied for the newly 
established Albert L. Tucker and Elizabeth T. Tucker 
Postdoctoral Fellowship earlier this year. The $1 million 
grant, available through the Albert L. Tucker and Elizabeth 
T. Tucker Foundation, supports the postdoctoral training 
program for promising young cancer researchers. This year, 
that researcher was Levin. 
“Having this award allows me to pursue a research year 
before I begin residency, which will allow me to strengthen my 
medical background and strengthen my science background 
before I start,” she explains. 
The fellowship is housed within the George Washington 
University Cancer Center, led by Eduardo M. Sotomayor, M.D. 
“We are very grateful for the support that has been 
provided by the Tucker Foundation,” he says. “It will enable 
us to provide valuable training to a fellow who will make a 
difference in the field of cancer research.” 
Levin, working in Mishra’s lab, is exploring liver cancer, 
one of the most common causes of cancer deaths worldwide. 
As she explains, there are two strands to her team’s research, 
“Targeting E3 Ligases in Liver and GI Cancer.” First, they 
identified the TGF-beta pathway, a cellular pathway that 
plays a variety of roles in liver cancer, including one as a tumor 
suppressant. Second, using the cancer genome atlas, a “huge 
catalog of genome sequencing and genetic mutations from 
cancer patients,” Levin explains, they found that a specific 
enzyme — E3 ligase — was altered in more than 50 percent of 
patients with liver cancer included in the atlas. 
“Looking at that specific enzyme, it actually targets part 
of the TGF-beta pathway for degradation,” Levin says. “The 
TGF-beta pathway is playing a tumor suppressive role, and the 
E3 ligases are degrading a piece of that pathway [and] stopping 
that tumor suppressive role, so we believe that we can target 
those E3 ligase enzymes with various treatments. We can 
actually restore that tumor suppression role of that pathway in 







For the second consecutive summer, 
John D. Evans and Steve Wozencraft 
welcomed members of the GW School of 
Medicine and Health Sciences (SMHS) 
to their Sag Harbor, New York, home 
for a special reception to benefit two 
SMHS organizations: The Research 
Center for the Eradication of HIV 
and The Rodham Institute for Health 
Care Provider Education to Eliminate 
Disparities. This year’s event took place 
aboard Evans and Wozencraft’s yacht, 
the Waterford. 
As a select group of guests cruised 
Sag Harbor Bay, Jeffrey S. Akman, M.D. 
’81, RESD ’85, vice president for health 
affairs, Walter A. Bloedorn Professor 
of Administrative Medicine, and dean 
of SMHS, as well as Douglas F. Nixon, 
M.D., Ph.D., Walter G. Ross Professor 
of Basic Science Research and chair 
of the Department of Microbiology, 
Immunology, and Tropical Medicine at 
SMHS, and Jehan El-Bayoumi, M.D., 
RESD ’88, founding director of The 
Rodham Institute and professor of 
medicine at SMHS, offered updates on 
the latest developments at SMHS.  
Grateful to Give
Clinical Care Inspires 
Gendron Family to Support 
Cancer Research Innovation
Philanthropy has myriad motivations; 
there are as many reasons to give as 
there are causes in need of support. 
For Roger J. and Susan Gendron, the 
reasons are simple: first, their son 
Theodore is a recent graduate of the 
George Washington University (GW) 
School of Business, earning a bachelor’s 
degree in business administration in 
May 2016; more significantly, however, 
Susan is a breast cancer survivor under 
the care of Robert Siegel, M.D. ’77, 
associate center director for education 
and training at the GW Cancer Center 
(GWCC) and professor of medicine at 
the GW School of Medicine and Health 
Sciences (SMHS).
“Dr. Siegel is a miracle worker and 
has been a comforting source of healing 
and inspiration,” Susan says.  She adds 
that her experiences at the GW Medical 
Faculty Associates and at GW Hospital 
were exceptional. “The staff, nurses, and 
physicians have made my journey much 
more bearable due to their compas-
sionate care and professionalism.”
In recognition of the treatment 
Susan received from Siegel, the couple 
made a $2.5 million gift to GWCC to 
establish the Gendron Family Cancer 
Research Fund. The fund will support 
basic and translational science research, 
as well as contribute to pilot research 
grants for residents and fellows. “Giving 
back is our way of saying thank you,” 
Susan says.
“We’re bringing innovative research 
to areas in need,” explains Eduardo M. 
Sotomayor, M.D., director of GWCC, 
director of the Division of Hematology 
and Oncology, and professor of medicine 
at SMHS. “We are not just repeating 
what other cancer centers are doing 
— we’re coming with our own set of 
unique ideas.”
Thanks to the Gendron family’s 
gift, he adds, the opportunities for 
collaboration around pilot funding 
resources will blossom, “dramatically 
increasing our capacity to impact both 
cancer research and clinical care.”  
Support from Sag Harbor
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Luther W. Brady Jr., M.D. ’48, HON ’04, 
B.A. ’46, A.A. ’44, was recently 
awarded his seventh honorary degree, 
from Complutense University in 
Madrid, Spain. 
Kenneth Fisher, M.D. ’68, recently 
published a book, Understanding 
Healthcare: A Historical Perspective 
(Freedom in Health Care, 2016). 
Ira Spar, M.D. ’68, RESD ’75, published 
his second book, Civil War Hospital 
Newspapers: Histories and Excerpts 
of Nine Union Publications (McFarland 
& Company, Inc., 2015). The book 
— a follow‑up to his 2013 work, New 
Haven’s Civil War Hospital: A History of 
Knight U.S. General Hospital, 1862–65 
(McFarland) — examines the founding 
and development of internal Union 
hospital newspapers, which were 
written and published by patients, 
during the Civil War. Spar is a U.S. 
Army Vietnam War veteran and is a 
board member with the Society of Civil 
War Surgeons. He is also president of 
the Hartford (Connecticut) Medical 
Society and a fellow with the American 
Academy of Orthopedic Surgeons. 
Steven E. Cohen, PA-C ’83, joined the 
SMHS faculty as a clinical instructor 
in the Physician Assistant (PA) Studies 
program. Previously, Cohen served as 
a senior neurosurgical PA at Suburban 
Hospital, a community‑based, not‑for‑
profit hospital serving Montgomery 
County, Maryland. 
Scott Rifkin, M.D. ’85, CEO of 
Mid‑Atlantic Health Care, won the 2016 
EY Entrepreneur of the Year award 
in the Maryland region in the growth 
category. The award recognizes entre‑
preneurs who demonstrate excellence 
and extraordinary success in such areas 
as innovation, financial performance, 
and personal commitment to their busi‑
nesses and communities. 
Lane R. Rosen, M.D., RESD ’97, 
medical director of radiation oncology 
at Willis‑Knighton Health System, was 
honored with the 2016 Louisiana State 
University–Shreveport Distinguished 
Alumni Award. 
Mark R. Greenwood, M.D. ’00, was 
selected as the new primary care 
clinical program medical director 
with Intermountain Medical Group. 
Greenwood is a board‑certified family 
medicine physician who has been 
practicing at Sevier Valley Clinic in 
Richfield, Utah, since 2003, and he has 
also served as the medical director in 
the medical group’s central rural region 
since 2012. 
Samantha Brugmann, Ph.D. ’05, 
received the Presidential Early Career 
Award in Science and Engineering 
(PECASE). Brugmann, an assistant 
professor of surgery at Cincinnati 
Children’s Hospital Medical Center, 
was among 105 researchers to 
receive the 2016 award, the highest 
honor bestowed by the United 
Alex Jeffrey Mechaber, M.D., RESD 
’97, FACP, professor of medicine and 
senior associate dean for under‑
graduate medical education at the 
University of Miami Miller School 
of Medicine, recently received 
the Dr. Bernard J. Fogel Chair in 
Medical Education for his 18 years of 
outstanding service to the school. 
“Alex was my first chief resident,” 
recalls Alan Wasserman, M.D., chair 
of the Department of Medicine and 
Eugene Meyer Professor of Medicine 
at SMHS. “I am very proud of his 
accomplishments.” 
Mechaber is just the second holder 
of the endowed chair, named in 
honor of former dean Bernard J. 
Fogel, M.D., who served from 1981 
to 1995. 
“I was both surprised and humbled 
when I was notified that I would 
be receiving the Fogel Chair,” says 
Mechaber, who graduated from the 
Miller School in 1994. “Bernie was my 
dean when I was in medical school, 
so to hold the chair named for him is 
especially meaningful to me.” 
Mechaber’s wife Hilit Mechaber, 
M.D., RESD ’98, also completed her 
internal medicine residency at GW 
and serves as associate dean for 
student services at the Miller School 
of Medicine. 
DISTINGUISHED AMONG US: GW School of Medicine and Health Sciences 
alumni, André J. Nahmias, M.D. ’57, M.P.H. (left), and Lieutenant General Nadja 
Y. West, M.D. ’88 (center), were among the recipients at the 80th Annual Alumni 
Achievement Awards ceremony on Oct. 27.
Nahmias, an Emeritus Professor of Pediatrics and Public Health at Emory 
University, was honored for his contributions to research, clinical care, education, 
and child advocacy. West is the 44th Surgeon General of the United States Army 
and Commanding General of the U.S. Army Medical Command. 
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States government on science and 
engineering professionals in the 
early stages of their independent 
research careers.
Jessica Langenhan, M.D. ’05, recently 
earned an M.B.A. with honors from the 
University of California–Los Angeles 
Anderson School of Management, 
graduating from the Fully Employed 
MBA program in June 2016. 
Langenhan was also named associate 
medical director of the substance 
abuse program at Laguna Treatment 
Hospital in July 2016. 
Daniel O’Neill, M.D. ’13, will practice 
general internal medicine at the 
Neighborhood Health Center in 
Portland, Oregon, serving as the 
anchoring internal medicine physician 
for the new clinic site for Portland’s 
underserved populations. O’Neill is 
a primary care physician specializing 
in HIV and LGBT health, who recently 
completed his residency training in 
internal medicine at Virginia Mason 
Medical Center in Seattle. 
IN MEMORIAM
Nicholas A. Balsano, M.D. ’65 
Gilbert D. Barkin, M.D. ’53, B.S. ’49 
James P. Burns, M.D. ’49, RESD ’52,  
A.A. ’45  
John Timothy Chapman, M.D. ’55 
Joseph Bernard Credle, M.D., RESD ’72 
Paul H. Daines, M.D. ’58, RESD ’78 
Justin Adam Dalton, H.S. ’05 (CERT) 
Neilson T. Debevoise, M.D. ’56 
Andrew M. Diggs, M.D., RESD ’53  
Albert F. Esch, M.D. ’54, M.A. ’50, B.S. ’49 
Cynthia A. Evans, M.D., RESD ’87 
John S. Featherston, M.D. ’46 
Edward E. Gahres, M.D., RESD ’59,  
M.A. ’51 
Joel S. Ganz, M.D. ’61  
Warren Gillette, M.D. ’50 
Thomas H. Gresinger, M.D. ’61, RESD ’66 
William M. Kane, M.D. ’54 
Adolphe C. Kiczales, M.D. ’55, A.A. ’49 
Jerome H. Komisarof, M.D., RESD ’60 
Harold Lichtenstein, B.S. ’49 
John Gage Mahaney, M.D. ’54 
Douglas B. McMullen, M.D. ’66 
Robert Mrkich, M.D. ’63 
Manfred R. Nelson, M.D. ’62 
Thomas M. O’Neill, M.D. ’65  
Beale H. Ong, M.D. ’59, B.A. ’55, A.A. ’53 
Ronald Ottenberg, M.D. ’59, RESD ’67, 
B.S. ’56, A.A. ’55  
Frederick Turner Reuter, M.D. ’44  
Surendra R. Rishi, M.D., RESD ’69 
Allan Schonberg, M.D. ’73  
Albert L. Sheffer, M.D. ’56 
Leo H. Siegel, M.D. ’43  
Charles G. Wellso, M.D. ’53  
Randall Owen, M.S.H.S. ’13, PA-C ’13, 
has been appointed as a research 
fellow in global health and social 
medicine at the Harvard Medical 
School for 2016–17. Owen, who 
completed his physician assistant 
surgical residency at the Norwalk 
Hospital/Yale School of Medicine, is a 
former medical operations specialist 
at NASA Johnson Space Center, 
where his research interests included 
the ethical and policy challenges 
surrounding the medical and 
surgical care delivery systems being 
developed to support long‑duration 
space missions. 
Andrace Deyampert, M.S.H.S. ’14, 
was among the recipients of the 2016 
U.S. Food and Drug Administration 
Outstanding Service Award. 
Jeff Farnsworth, DPT ’15, has been 
named director of physical therapy at 
the National Sports Medicine Institute 
in Virginia. 
Save the Date!
This year we are celebrating the reunions for the M.D. classes from
1967, 1972, 1977, 1987,   
1992, 1997, and 2007
Get involved now by contacting 
smhsalumni@gwu.edu or (202) 994–7511
REUNION WEEKEND 2017
September 15 –17, 2017
See you back  
on campus soon!
Untitled-1   1 11/30/16   2:15 PM
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S
cholarship support is helping many 
of our students fulfill their dreams of 
becoming health care professionals. 
Extraordinary, long-term financial 
sacrifices are often required to pursue degrees 
in medicine and the health sciences. The debt 
burden facing graduates across the country can 
be severe. Among GW’s Class of 2016 M.D. 
program students, more than half graduated with significant debt, some 
with obligations exceeding $200,000. Those are daunting figures. 
Likewise, students in the health sciences programs often leave 
campus with large debt loads. In a survey of the Class of 2016 physical 
therapy and physician assistant students, a sizable percentage reported 
six-figure debt. 
The high cost of pursuing an education in an expensive city 
such as Washington, D.C. limits the school’s ability to recruit top 
students, especially those from less affluent families. The availability of 
scholarships can address that situation. We want to ensure that when 
students face career decisions — such as which specialty to choose 
or where to practice — they are free to base those decisions on their 
passions and callings, and not on financial anxiety and pressure. 
We need to tackle this problem by finding ways to reduce the debt 
load. Scholarships are one of the most effective tools for accomplishing 
this task. To that end, we are working to raise at least $4.5 million 
in new scholarships this academic year through philanthropic 
contributions. Our  website, smhs.gwu.edu, provides detailed 
information on this effort. 
GW already offers more than 70 endowed scholarships in the 
School of Medicine and Health Sciences (SMHS). The benefactors who 
created those scholarships as well as those who contribute to them have 
always expressed satisfaction in being able to help others, particularly 
students pursuing their dreams in medicine and the health sciences. 
We want to ensure that no qualified student is forced to pass 
up a career in medicine or the health sciences because the cost of 
education is too high. The goal of SMHS is not only to attract the best 
and brightest students to GW, but also to help reduce or eliminate 
the crushing financial burden that they can face upon graduation. All 
alumni and friends are invited to participate in the SMHS scholarship 
campaign. For information about supporting our scholarship fund, 
please contact Sumana Chatterjee at (202) 994-6724 or schatter@gwu.
edu. Please join us in this cause. 
Sincerely, 
Dennis Narango, M.A., CFRE
Associate Dean, SMHS, and Associate Vice President for  
GW Medicine Development and Alumni Relations
P.S. If you are 70 ½ or older, you can take advantage of a simple way to benefit 
the GW School of Medicine and Health Sciences and receive tax benefits 
in return. You can give up to $100,000 annually from your IRA directly to 
SMHS without having to pay income taxes on the money. These gifts count 
toward your IRA’s minimum distribution requirements and benefit you 
regardless of whether you itemize deductions on your income tax returns. 
Visit gwu.planmylegacy.org/ira-charitable-rollover for more information.
IN DEVELOPMENT SMHS Board of Advisors
Stuart S. Kassan, M.D. ’72, FACP, MACR, Co-Chair 
Rheumatology; Distinguished Clinical Professor of Medicine, 
University of Colorado‑Denver School of Medicine; Chief Medical 
Officer, Multispecialty Physician Partners; GW Board of Trustees
Lara S. Oboler, M.D. ’95, Co-Chair 
Cardiology; Lenox Hill Heart & Vascular Institute
Gary M. Abramson 
Partner, the Tower Companies
Christopher L. Barley, M.D. ’93 
Internal Medicine; Clinical Assistant Professor of Medicine, 
Cornell/Weill School of Medicine
Constance Urciolo Battle, M.D. ’67, FAAP 
Pediatrics and Public Health
Luther W. Brady Jr., M.D. ’48, HON. ’04, B.A. ’46, A.A. ’44 
Radiation Oncology; Affiliated Faculty, Department of 
Radiation Oncology, Drexel University College of Medicine; 
GW Emeritus Trustee
Carlos R. Diaz, M.D. ’72, RESD ’75 
President and Owner, Aeromedical Services
Daniel Ein, M.D., FACP, FAAAAI, FACAAI 
Allergy, Asthma, and Immunology; Clinical Professor of 
Medicine, GW School of Medicine and Health Sciences; Director, 
Allergy & Sinus Center, GW Medical Faculty Associates
Thomas E. Flynn, M.D. ’86 
Ophthalmology, Ellsworth Uveitis & Retina Care
Jeanne G. Holzgrefe, M.D. ’96, Ph.D., M.P.H. 
Psychiatry; Chevy Chase Psychiatric Services; Assistant 
Clinical Professor of Psychiatry and Behavioral Sciences, GW 
School of Medicine and Health Sciences
Floyd Alexander Katske, M.D. ’76, RESD ’77 
Urology; Clinical Assistant Professor of Urology, David Geffen 
School of Medicine, UCLA
Jay E. Katzen, M.D. ’72, B.A. ’67 
Ophthalmology; The Eye Center; GW Board of Trustees
Kerry L. Kuhn, M.D. ’73, RESD ’77, B.A. ’70, FACOG 
OB/GYN; Private Practice; Senior Vice President of VitalMD
Gerald S. Lazarus, M.D. ’63 
Dermatology; Professor of Dermatology, Johns Hopkins 
University; Former Member, GW Board of Trustees
John C. Pan, M.D. ’70, RESD ’74 
OB/GYN; Founder, Center for Integrative Medicine, GW 
School of Medicine and Health Sciences
Smita H. Patel, M.D., DFAPA 
Psychiatry, Assistant Clinical Professor of Psychiatry and 
Behavioral Science, GW School of Medicine and Health Sciences
Richard G. Popiel, M.D. ’81, RESD ’83, M.B.A., B.S. ’75 
Internal Medicine; Executive Vice President, Healthcare 
Services, Chief Medical Officer, Cambia Health Solutions & 
Regence Health Insurance Company
Rakesh C. Sahni, M.D. 
Cardiology; Maryland Cardiology Associates
Mark W. Surrey, M.D. ’72, FACOG, FACS 
OB/GYN‑Reproductive Endocrinology; Professor & Clinical 
Director, Reproductive Surgery, UCLA; Co‑Founder and 
Medical Director, Southern California Reproductive Center
Allan B. Weingold, M.D., HON. ’98 
OB/GYN; Professor Emeritus, Former Chair of OB/GYN, 
Former Vice President for Medical Affairs and Executive Dean, 
The George Washington University
Art B. Wong, M.D. ’67 
Emergency Medicine; Founder, Emergency Physicians 
Medical Group, PC
The SMHS Board of Advisors offers the dean of the School of Medicine and Health 
Sciences recommendations on strategic priorities and important issues for the school, and 
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2600 Virginia Ave., NW
Suite 329
Washington, DC 20036
THE POWER AND PROMISE OF MEDICINE
Marcus Mitchell, a fourth-year medical student at SMHS and recipient of the Power and Promise scholarship, 
found himself relieved with the reduction of his student loan debt and inspired to give back. “I want to have my 
own scholarship fund,” he says, “and help some [unsuspecting] student who’s doing a good job.”  
Read more on page 29.
